Fabrication and Characterization of Sol-Gel Based Nanoparticles for Drug Delivery by Yadav, Reeta
City University of New York (CUNY)
CUNY Academic Works
Dissertations, Theses, and Capstone Projects Graduate Center
10-2014
Fabrication and Characterization of Sol-Gel Based
Nanoparticles for Drug Delivery
Reeta Yadav
Graduate Center, City University of New York
How does access to this work benefit you? Let us know!
Follow this and additional works at: https://academicworks.cuny.edu/gc_etds
Part of the Biochemistry Commons
This Dissertation is brought to you by CUNY Academic Works. It has been accepted for inclusion in All Dissertations, Theses, and Capstone Projects
by an authorized administrator of CUNY Academic Works. For more information, please contact deposit@gc.cuny.edu.
Recommended Citation
Yadav, Reeta, "Fabrication and Characterization of Sol-Gel Based Nanoparticles for Drug Delivery" (2014). CUNY Academic Works.
https://academicworks.cuny.edu/gc_etds/397
  
 
 
FABRICATION AND CHARACTERIZATION  
OF  
SOL-GEL BASED NANOPARTICLES  
FOR DRUG DELIVERY  
 
by  
 
Reeta Yadav  
 
 
 
 
 
 
 
 
A dissertation submitted to the Graduate Faculty in Biochemistry in partial fulfillment of 
the requirements for the degree of Doctor of Philosophy. City University of New York  
2014 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 
REETA YADAV 
All Rights Reserved 
iii 
 
 
 
 
This manuscript has been read and accepted for the  
Graduate Faculty in Biochemistry in satisfaction of the  
dissertation requirement for the degree of Doctor of Philosophy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Uri Samuni 
 
George John 
 
Hiroshi Matsui 
 
Sanjai Kumar 
 
Glendon Dale McLachlan 
Supervisory Committee 
 
THE CITY UNIVERSITY OF NEW YORK 
 
 
 
_____________________ 
Uri Samuni 
 
 
 Date  
 
 
 
 
 
_____________________ 
Chair of Examining Committee 
 
 
 
Edward Kennelly 
 
 Date  Executive Officer 
iv 
 
Abstract 
FABRICATION AND CHARACTERIZATION OF SOL-GEL BASED 
NANOPARTICLES FOR DRUG DELIVERY 
By 
Reeta Yadav 
 
Adviser: Professor Uri Samuni  
Nanogels are cross linked polymeric sol-gel based nanoparticles that offer an interior network for 
incorporation and protection of biomolecules, exhibiting unique advantages for polymer based 
delivery systems. We have successfully synthesized stable sol-gel nanoparticles by means of [a] 
silicification reactions using cationic peptides like polylysine as gelating agents, and [b] 
lyophilization of sol-gels. Macromolecules such as Hemoglobin and Glucose Oxidase and small 
molecules such as Sodium Nitroprusside (SNP) and antibiotics were encapsulated within the 
nanogels. We have used transmission electron microscopy, dynamic light scattering, zeta 
potential analysis, and spectroscopy to perform a physicochemical characterization of the 
nanogels resulting from the two approaches. Our studies have indicated that the nanogel 
encapsulated proteins and small molecules remain intact, stable and functional.  
A Hydrogen Peroxide (H2O2) and Nitric Oxide (NO) generating drug carrier was 
synthesized using these nanogels and the effect of generation of H2O2 from Glucose Oxidase  
encapsulated nanogels and NO from SNP encapsulated nanogels was tested on E.coli. The 
results show that the nanoparticles exert antimicrobial activity against E.Coli, in addition NO 
generating nanogels potentiated H2O2 generating nanogels induced killing. These data suggest 
that these NO and H2O2 releasing nanogels have the potential to serve as a novel class of 
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antimicrobials for the treatment of multidrug resistant bacteria. The unique properties of these 
protein/drug incorporated nanogels raise the prospect of fine tailoring to specific applications 
such as drug delivery and bio imaging.  
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CHAPTER 1 
INTRODUCTION 
Rapid developments in the pharmaceutical drug discovery are resulting in an increasing 
number of novel therapeutic drugs for the treatment of a variety of diseases. However, the main 
problems associated with systemic drug administration for most diseases still remain, which 
includes the even bio distribution of administered pharmaceuticals throughout the body, the lack 
of drug specific affinity toward a pathological site, nonspecific toxicity and other side effects 
resulting from high doses. There has been a rapid growth of interest in the use of nanotechnology 
and nanoparticles. Nanoparticle based drug delivery and drug targeting systems aim to minimize 
drug degradation and inactivation upon administration, prevent undesirable side effects and 
increase drug bioavailability. The use of nanoparticles as pharmaceutical carriers to enhance the 
in vivo efficiency of many drugs has been well established over the past decade, in both 
pharmaceutical research and the clinical setting [1]. 
The key parameters in the design and formulation of carrier systems are preparation and 
entrapment method, size, stability and degradation characteristics of the bioactive-carrier 
complex as well as release kinetics of the entrapped material. In general biodegradable and bio 
absorbable carriers are preferred so that they would degrade inside the body by hydrolysis or by 
enzymatic reactions, without producing any toxic products. Over the years numerous techniques 
have been developed for the preparation of the carrier systems and entrapment of bioactives to 
these carriers [2]. However, most of these methods are not suitable for entrapment of sensitive 
substances because of their exposure either to mechanical stresses (e.g. high-shear 
homogenization, sonication, high pressures), potentially harmful chemicals (e.g. volatile organic 
solvents, detergents), or low/high values of pH during the preparation. Many of these preparation 
techniques require the application of harmful volatile solvents (e.g. chloroform, ether, methanol, 
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acetone) to solubilize the ingredients. Such solvents not only affect the chemical structure of the 
entrapped substance but also may remain in the final formulation and contribute to toxicity and 
influence the stability of the carrier systems. In general, residual organic solvents have no 
therapeutic benefits, but may be hazardous to human and animal health as well as the 
environment [2-4]. In addition to the above mentioned disadvantages, use of volatile organic 
solvents necessitates performance of two further steps in the synthesis of the carrier systems: i) 
removal of these solvents, and ii) assessment of the level of residual organic solvents in the 
formulations.  
Nanogels are a recent addition to the list of known physical nanocarriers, which have 
found applications as drug delivery systems. The term ‘nanogels’ defines dispersions of hydrogel 
particles formed by physically or chemically cross-linked polymer networks of nanometric 
dimensions. Hydrophilic particles with high dispersion stability can be produced by loading 
biological agents and drugs into nanogels via a spontaneous process including interactions 
between the agent and the polymer matrix. Studies have shown that nanogels were able to 
physically protect biological molecules from degradation in vivo and have been investigated for 
different types of active molecules, ranging from small drugs to bio macromolecules [3]. 
Nanogels show excellent potential as drug delivery carriers because of their high loading 
capacity, high stability and responsiveness to environmental factors, such as ionic strength, pH, 
and temperature that are unprecedented for common pharmaceutical nanocarriers [1].  
Many approaches have been used for the preparation of nanogels, most of which can be 
divided into 1) physical self-assembly of interactive polymers; 2) polymerization of monomers in 
a homogeneous phase or in a micro or nanoscale heterogeneous environment; 3) crosslinking of 
preformed polymers; and 4) template assisted nanofabrication of nanogel particles [3]. A method 
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of great interest is the sol-gel process, which is a wet-chemical technique widely used in the 
fields of materials science and ceramic engineering. Sol-gel materials are prepared by generation 
of colloidal suspensions (“sols”) which are subsequently converted to viscous gels and thence to 
solid materials. Typical precursors for this gel are metal alkoxides, which undergo various forms 
of hydrolysis and polycondensation reactions. Lately there has been considerable increase in sol-
gel synthesized materials for biological applications as they offer many advantages compared to 
other conventional methods. The temperatures required for most stages are close to room 
temperature thus minimizing any thermal degradation of both the material itself and any 
entrapped species, leading to high purity and higher yield. Due to the mild temperature and pH 
conditions used, pH sensitive organic species (e.g. Dyes) and even biological species including 
enzymes and whole cells can be entrapped and still retain their functions. Another reason why 
this technique is valuable is because appropriate chemical modification of the precursors, can 
give control over the rates of hydrolysis and condensation and thus change colloid particle size 
and the pore size, porosity and pore wall chemistry of the final material. Also it is possible to do 
covalent attachment of organic and biological species to porous silicate glass structures using 
functionalized precursors [4,5]. All these properties of sol-gel are very useful for an optimal 
nanotherapy because it is important that the therapeutic molecule is protected from degradation 
and reach its targeted intracellular locations without interactions with non-target cells.  
Interestingly, certain organisms such as diatoms (Figure 1) have developed mechanisms 
for generating intricate structures based on silica. This formation of in vivo silica based structures 
has been studied in depth and it is known that biosilicification occurs under mild 
physicochemical conditions. A recent work published in Science by Kroger et al.[6] has shown 
that silica precipitating proteins (silaffin proteins) such as R5 (Figure 2) from the diatom 
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Cylindrotheca fusiformis can catalyze the precipitation of silica within seconds when added to a 
solution of silicic acid with a resulting material of fused spherical silica particles with an average 
diameter of 500nm [7-9]. Entrapment and enzyme immobilization studies done with 
butyrylcholinesterase and catalase have revealed that biosilica not only provides an excellent 
immobilization and matrix support but also retains 90% of the enzyme activity [8].  
 
 
 
 
 
 
 
Thus biosilicification reactions catalyzed by silica precipitating peptides can be used as a 
new route for the entrapment of an exogenously added enzyme or drug in the silica matrix. Use 
of Poly-L-Lysine (PLL) (Figure 2) which is also a silica precipitating peptide has the additional 
advantages of utilizing the chemical properties of lysine for functionalization of the nanoparticles 
and selective binding of bioactive agents. Naik et al. have shown that the formation of biosilica 
structures can be controlled by manipulation of the physical reaction environment; they showed 
several silica nanomorphologies ranging from common spheres to highly organized and complex 
fibrillar morphologies, catalyzed by the R5 peptide under varied conditions [9]. 
 
Figure 1. Diatoms, a. Coscinodiscus; b. Stephanodiscus; c. Lyrella hennedyi. Diatoms develop 
intricate structures based on silica. [Mann, David G. 2010. Diatoms. Version 07 February 2010. 
http://tolweb.org/Diatoms/21810/2010.02.07 in The Tree of Life Web Project, http://tolweb.org/] 
a b c 
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THE SOL-GEL PROCESS  
The term sol-gel refers to a process in which solid nanoparticles dispersed in a liquid (a sol) 
agglomerate together to form a continuous three-dimensional network extending throughout the 
liquid (a gel). The sol-gel process is a method for producing solid materials from small 
molecules. The method is used for the fabrication of metal oxides, especially the oxides of 
silicon and titanium. Typical precursors are metal alkoxides and metal chlorides, which undergo 
hydrolysis and polycondensation reactions to form a colloid. The basic structure or morphology 
of the solid phase can range anywhere from discrete colloidal particles to continuous chain-like 
polymer networks [5]. 
In either case (discrete particles or continuous polymer network) the sol leads to the formation of 
an inorganic network containing a liquid phase (gel). Formation of a metal oxide involves 
connecting the metal centers with oxo (M-O-M) or hydroxo (M-OH-M) bridges, therefore 
generating metal-oxo or metal-hydroxo polymers in solution. A drying process serves to remove 
the liquid phase from the gel, yielding a micro-porous amorphous glass.  
A well-studied alkoxide is tetramethyl orthosilicate (TMOS). The chemical formula for TMOS is 
given by Si(OCH3)4, or Si(OR)4, where the alkyl group R = CH3. Alkoxides are ideal chemical 
Figure 2. R5 Peptide (Top) and structure of Poly-L-Lysine (bottom) 
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precursors for sol-gel synthesis because they react readily with water. In a hydrolysis reaction, a 
hydroxyl ion becomes attached to the silicon atom as follows: 
Si(OR)4  + H2O → HO-Si(OR)3 + R-OH 
 
Depending on the amount of water and catalyst present, hydrolysis may proceed to completion to 
silica: 
Si(OR)4  + 2 H2O → SiO2 + 4 R-OH 
Complete hydrolysis requires a significant excess of water and catalysts such as acetic acid or 
hydrochloric acid. Intermediate species include [(OR)2–Si-(OH)2 ] or [(OR)3 –Si-(OH)], resulting 
from partial hydrolysis reactions. Two partially hydrolyzed monomers would result in early 
intermediates linked via a siloxane [Si–O–Si] bond: 
(OR)3 –Si-OH + HO–Si-(OR)3 → [(OR)3Si–O–Si(OR)3] + H-O-H 
or 
(OR)3 –Si-OR + HO–Si-(OR)3 → [(OR)3Si–O–Si(OR)3] + R-OH 
Thus, polymerization is associated with the formation of a 1, 2, or 3- dimensional network of 
siloxane [Si–O–Si] bonds accompanied by the production of H-O-H and R-O-H species (Figure 
3). 
Condensation liberates a small molecule, such as water or alcohol. This type of reaction can 
continue to build larger and larger silicon-containing molecules by the process of 
polymerization. The hydrolysis and polycondensation reactions initiate at numerous sites within 
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the TMOS + H2O solution as mixing occurs. When sufficient interconnected Si-O-Si bonds are 
formed in a region, they cooperatively form colloidal (submicrometer) particles or a sol. The size 
of the sol particles and the cross-linking within the particles (i.e., density) depend upon the pH 
and R ratio (R = [H2O]/[Si(OR)4]) Polymerization of silicon alkoxide, for instance, can lead to 
complex branching of the polymer, because a fully hydrolyzed monomer Si(OH)4 is 
tetrafunctional. Alternatively, under certain conditions such as low water concentration fewer 
than 4 of the OR or OH groups (ligands) will be capable of condensation, so relatively little 
branching will occur. The mechanisms of hydrolysis and condensation, and the factors that direct 
the structure toward linear or branched structures are the most critical issues of sol-gel science 
and technology. This reaction is favored in both basic and acidic conditions [10]. 
 
 
 
 
 
 
 
 
 
 
Figure 3. Simplified representation of condensation of TMOS 
in the sol-gel process. (Top) Tetra methyl ortho silicate 
monomer and (bottom) the sol-gel matrix 
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Since the sol is a low-viscosity liquid, it can be cast into a mold. The mold must be selected to 
avoid adhesion of the gel. With time the colloidal particles and condensed silica species link 
together to become a three-dimensional network. The physical characteristics of the gel network 
depend greatly upon the size of particles and extent of cross-linking prior to gelation. At 
gelation, the viscosity increases sharply, and a solid object results in the shape of the mold. 
Aging of a gel involves maintaining the cast object for a period of time, hours to days, 
completely immersed in liquid. During aging, polycondensation continues along with localized 
solution and re-precipitation of the gel network, which increases the thickness of interparticle 
necks and decreases the porosity. The strength of the gel thereby increases with aging. An aged 
gel must develop sufficient strength to resist cracking during drying [4,5,10]. 
 
 Although several studies have demonstrated the synthesis of silicate particles using 
synthetic peptides and polyamines, there is not much work done on physicochemical 
characterization and optimization of these particles which is much needed before they can be 
used for therapeutic drug delivery. Our aim with our experiments was to extend these studies and 
find optimum synthetic conditions to produce stable sol-gel based nanoparticles which can be 
fabricated and characterized for drug delivery and a wide number of other applications. We 
report here use of two different sol-gel based techniques to synthesize nanogels (i) Sol-gel 
lyophilization technique and (ii) a biomimetic polycationic peptide technique.  We also 
performed a physicochemical characterization of the resulting nanogels from the two techniques 
and report future applications.  
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CHAPTER 2 
 
SYNTHESIS OF SOL-GEL BASED NANOPARTICLES- 
DIFFERENT APPROACHES 
 
 
Two different approaches were used for synthesis of sol-gel based nanoparticles, the 
Polycationic peptide protocol and the Lyophilization protocol.  Both approaches start out with 
the hydrolysis and condensation of a common precursor alkoxide, Tetramethyl ortho silicate 
(TMOS) (Figure 4). Once the colloidal solution (sol) of TMOS is formed, (i) nanoparticles can 
be precipitated out of the sol using polycationic peptides such as Poly-L-Lysine (PLL) or (ii) the 
sol can undergo further condensation and polymerization reactions leading to continuous glass 
like gels which can be lyophilized to yield sol-gel based nanogels.  
10 
 
 
 
 
 
UNIFORM PARTICLES 
WET GEL/SOL-GEL 
Metal 
Alkoxide 
Solution 
    SOL 
Hydrolysis  
Polymerization 
Gelling  
Precipitation 
Drying  
Lyophilization  
NANOPARTICLES 
Figure 4. General Scheme for synthesis of sol-gel based nanoparticles  
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Polycationic peptide protocol 
“The polycationic peptide protocol” is based on the use of polycationic peptides such as 
Polylysine for precipitating out sol-gel nanoparticles from a colloidal solution of TMOS (Figure 
5). This protocol is a modified protocol based on methods used by Naik et al. (2004) [8].  
The following standard procedure was used for synthesis of all nanogels using polypeptides: 
TMOS (sigma, >99 % purity) was hydrolyzed by adding 1mM HCl (1:5 ratio) and sonicated for 
30 minutes. Then 50 mM of Potassium Phosphate buffer pH 7 with the desired protein or 
molecule was mixed with the hydrolyzed TMOS solution. The mixture was left standing for 5 
minutes at room temperature. 1ml deionized water was added to terminate the reaction. The 
solution was washed by centrifugation 3 times. After the final wash the particles were re-
suspended in phosphate buffer. To make control nanogels no protein is added to the buffer.  
When polylysine is used as the silica precipitating agent in the polycationic protocol then it 
would be referred to as “Polylysine protocol”. 
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Phosphate Buffer + Protein/Drug 
+Cationic peptide +TMOS solution. 
 
 
  
 
Reaction 
time 5 min 
add water     
 
centrifuge wash 
Resuspended 
in buffer  
Nanogels 
Figure 5. Synthesis of nanogels using Polycationic peptide protocol. 
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Lyophilization Protocol  
“The lyophilized protocol” involves encapsulating the desired molecules inside a polymeric sol-
gel matrix followed by a stage where the matrix is dried and finally lyophilizing the dried gel 
matrix (Figure 6).  
The following standard procedure was used for synthesis of all nanogels using lyophilization: 
TMOS was hydrolyzed by adding 2mM HCl (2:1 ratio) and sonicated for 30 minutes.    
Desired concentration of protein or small molecule was added to 50mM phosphate buffer pH 7. 
The buffer/protein mixture was added to hydrolyzed TMOS (1:1 ratio) and mixed and casted in 
desired container. The solution formed uniform gels in 30 seconds to 1 minute. The casted gel 
was washed with buffer 3 times to remove side products from surface of the gel. For control gels 
no protein was incorporated in the buffer.  
To make nanogels, the sol-gel films were slightly crushed using a spatula and dried at room 
temperature for 12 hours and lyophilized for 5 hours (LABCONCO, freezone). 
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Figure 6. Synthesis of nanogels using Lyophilization protocol. 
50mM Phosphate 
Buffer pH 7 + 
Drug/Protein  
TMOS solution 
(2mM HCl + TMOS) 
Sol-gel film  Nanogels 
Lyophilization  
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CHAPTER 3 
PHYSICOCHEMICAL CHARACTERIZATION OF NANOGELS 
The application of any nanocarrier platform requires high degree of control over their 
physicochemical properties. We performed systematic physicochemical studies including size 
distribution and aggregation, protein stability, protein/sol-gel interactions and protein release 
from sol-gel. The synthesis of particles was studied by varying different conditions like 
temperature changes, varying buffer and salt concentrations, different chain lengths of cationic 
polypeptides. Size characterization, particle morphology, size distribution and aggregation was 
studied by Transmission Electron Microscopy (TEM) combined with Dynamic Light Scattering 
(DLS). Protein stability, protein sol-gel interaction and release were studied using UV/Visible 
absorption spectroscopy. Characterization of surface properties of nanoparticulate carriers is 
complicated by charges of the different components of the nanospheres, the composition of the 
dispersion medium, and the extent of binding of biomolecule onto the nanoparticle. Thus we use 
Zeta potential measurements to study the surface properties and formulation stability of the 
particles. 
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EXPERIMENTAL PROCEDURES  
Dynamic Light Scattering (DLS) and Zeta Potential Analysis  
DLS measurements were performed on a 90 plus particle size analyzer (Brookhaven Instruments 
Corporation) employing a 90° scattering angle and a 35 mW incident laser (658 nm). Small 
amounts of nanogels (1-2mg) were suspended in deionized water and sonicated for 15 minutes 
before taking measurements. The reported diameter is the average of 5 runs for each sample. 
Zeta Potential measurements were done by adding small amount (1-2mg) of nanogels in 1mM 
KCl solution and sonication for 15 minutes. (Brookhaven Instruments Inc. Zeta Plus). 
Transmission Electron Microscope (TEM) Studies  
Dilute samples used for DLS measurements were mixed in a 1:1 ratio with 1% uranyl acetate, 
sonicated for 10 minutes. Then 5ul was put on a carbon film coated copper grid, 300 mesh 
(electron microscopy sciences, Hatfield, PA) and the excess solution was removed immediately 
using absorbent paper. The grids were dried overnight and viewed under the transmission 
electron microscope (JEOL, model JEM-1200 EX). Images were taken with a SIA–L3C CCD 
camera (Scientific Instruments and Applications, Inc.) using the software Maxim DL5 
(Diffraction Limited, Ottawa, Canada). 
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SIZE AND ZETA POTENTIAL ANALYSIS OF NANOGELS USING DYNAMIC LIGHT 
SCATTERING 
DLS studies have indicated that different populations are present in nanogel solutions prepared 
using the Lyophilization method. The particle diameter ranges from 80 to 300nm.  
For particles prepared using the polylysine protocol the particles range in size from 300 to 
500nm with multimodal population.  
These measurements correlate with TEM images (Figure 7 and 8) for both kinds of nanogels 
showing multiple populations. 
Zeta potential (a measure of colloidal stability) measurements indicate that the lyophilized 
nanogels have a negative charge with zeta potential of -30mV, whereas PLL precipitated 
nanogels have a lower colloidal stability with a zeta potential of -8mV.  
It was found that protein or the surfactant Polyethylene Glycol (PEG) (PEG is a steric stabililizer 
with various advantages discussed in Chapter 4) incorporation inside nanogels during the 
gelation step has no effect on zeta potential, indicating that incorporation of molecules inside the 
nanogel matrix does not affect its colloidal properties.  
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SIZE ANALYSIS OF NANOGELS USING TRANSMISSION ELECTRON MICROSCOPE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. TEM micrograph of control Nanogels synthesized using the 
Lyophilization protocol. The average nanoparticle size range is 50-
100 nm, Scale Bar: 0.5 µm. 
Figure 8. TEM micrograph of control nanogels using the Polylysine 
protocol). The average nanoparticle size range is 100-300nm, Scale Bar: 0.5 
µm. 
0.5 µm 
0.5 µm 
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Studies from Transmission Electron Microscope (Figure 7 and 8) suggest that the lyophilized 
nanogels are uniformly dispersed circular particles with a size range of 10nm to 200nm most of 
the particles being 60nm. Presence or absence of encapsulated proteins or molecules inside the 
nanogels did not have a considerable effect on the nanogel’s size and distribution as shown in 
further chapters. The polylysine precipitated nanogels have a slightly larger size of 100 to 300 
nm. 
Characterization of Nanogels under different conditions.  
The size dependence on Phosphate concentration in the range 3-200 mM was tested  
and there was no correlation with the resultant nanogel size (Table 1). Slight differences seen in 
the particle size are attributed to error in the instrument and changes due to solution stability. 
 
 
 
 
 
 
 
 
 
Phosphate Buffer Concentration Effective Diameter (nm)  
 3mM 143 
10mM 138 
30mM 207 
100 mM 240 
200 mM 210 
 
Table 1. Size of nanogels dispersed in phosphate buffers of different 
concentrations as obtained from Dynamic Light scattering instrument. 
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Tests utilizing Potassium Chloride, Citrate buffer, TRIS- HCl as buffers for suspension of 
nanogels resulted in similar results and showed no effect on particle size of the particles.  
The solubility of nanogels was also probed under different pH conditions (pH range: 5-7.5) and it 
was seen that there was no marked effect on the stability and size distribution of the nanogels 
when exposed to these pH conditions. Exposure to highly acidic conditions (pH 2) had no effect 
whereas exposure to highly alkaline conditions (pH 10-12), show smaller sizes of nanogels. This 
effect is discussed in more detail in later sections of this chapter.  
As discussed earlier the nanogels synthesized from the Polylysine protocol have a tendency to 
aggregate and are not colloidally stable for long periods of time (as compared to the nanogels 
produced from Lyophilization protocol). The stability and size of these particles were studied 
using the surfactant Polyethylene Glycol (PEG) to decrease aggregation and improve stability. 
Addition of increasing concentrations of PEG-400 decreased the size of the particles as tested by 
the DLS, showing low aggregation (Table 2). The Zeta Potential also became increasingly 
negative for the nanoparticles showing higher colloidal stability due to low aggregation (Table 
3).  
 
   Table 2. The change in effective diameter of the nanoparticles  
                                           with increasing amounts of PEG-400 added into suspending buffer. 
                                           The effective diameter of the nanoparticles decreases as the PEG  
                                           content increases. 
[PEG-400] (%v/v) Effective diameter of ngs (nm) 
0 800 
1.25 380 
2.5 500 
3.75 450 
5 390 
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                                              Table 3. The change in zeta potential of nanogels with increasing  
                                      amounts of PEG-400 added  into the suspending buffer . The zeta potential  
                                      of the nanoparticles becomes increasingly negative as higher amounts of PEG  
                                      added suggesting greater colloidal stability.  
 
 
 
 
 
 
 
 
RELEASE STUDIES ON ENCAPSULATED MOLECULES –Polylysine 
protocol 
Release of encapsulated molecules was tested using UV/Visible spectroscopy.  The protein Met -
Myoglobin (Met-Mb) was incorporated inside the nanogels synthesized using the polylysine 
protocol (encapsulation confirmed by UV spectra showing characteristic absorbance peak at 407 
nm) (Figure 9) and the release of protein from the nanogels was tested by suspending the 
particles in pH 7 phosphate buffer and spinning down the particles at different time intervals to 
measure the Met-Mb characteristic O.D at 407nm in the supernatant (Figure 10). 
 
 
 
[PEG-400] (% v/v) Zeta Potential of ngs (mV) 
0 -8 
0.25 -16 
0.5 -13 
0.75 -19 
1 -27 
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Figure 9. UV/Visible spectra of Met-Mb in solution and Met-Mb 
encapsulated nanogels. Characteristic peak of Met-Mb at 407nm 
suggests the encapsulation of the protein inside nanogels.  
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About 40% of the protein is released within 5 minutes. The remaining is released through a slow 
and steady rate. The release of the protein from polylysine protocol nanogels is spontaneous. 
Figure 10. a. UV/Vis spectra of Met Mb released into bathing buffer at 
different time intervals. b. Release of incorporated Met-Myoglobin from 
nanogels (synthesized by Polylysine protocol). O.D at 407nm was used to 
determine the % release of Mb from the nanogels.  
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Once synthesized the encapsulated protein readily diffuses out of the porous matrix. 
Encapsulation of other filling molecules such as surfactants (PEG, cellulose, other polymers) 
inside the matrix may be able to provide more control over release properties of these peptide 
precipitated nanogels for application where the molecules are required to stay inside the nanogels 
for a longer period of time.  
RELEASE STUDIES ON ENCAPSLATED MOLECULES (Sol- gel films) 
Protein release studies were carried out on sol-gel films to evaluate release properties of the sol-
gel matrix and gain insight into similar properties of synthesized nanoparticles. The studies were 
done on Hemoglobin (Hb) (Hb is discussed in detail in Chapter 5) encapsulated nanogels using 
UV/Visible spectroscopy. These studies were performed under different pH conditions. The 
effect of concentration and temperature was also studied for possible changes in release patterns. 
Sol-gel films containing Hemoglobin were casted on sides of standard cuvettes using our 
standard sol-gel procedure and bathed in phosphate buffers with varying pH’s (pH 2-12) , ionic 
concentrations (5mM, 50mM, 200mM, 500mM) and temperatures (10
o
C, 23
o
C, 35
o
C). The 
bathing buffer was separated at different time intervals and probed using UV/Visible spectra to 
test release of protein into the buffer detected by characteristic Hb absorbance at 405nm. The 
measured absorbance was correlated to % protein released over time.  
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Results  
There is no evidence for Hb release from the sol-gel matrix under buffer conditions of pH 2-8,  
indicating it remains trapped within the matrix. However there is substantial release under 
alkaline conditions (Figure 11). About 60% of the protein is released from the sol-gel film in 2 
hours when exposed to pH 12. (Table 4) 
 
Table 4. Release of Hb from sol-gel films under different pH conditions. Release of Hb from sol-gel films was 
measured by taking O.D of bathing buffer at 405nm over different time intervals and correlated to % release.  
pH Hemoglobin release 
2 
 
4.5  
5.5                  NO RELEASE  
6                 
7  
8  
10 0.6 % released in 2 hours  
12 Substantial release, about 0.5 % /min. Approx. 60% released in 2 
hours. 
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Similar release experiments were performed with Myoglobin encapsulated sol-gel films and it 
was seen that there is no release of Myogobin from sol-gel films at pH 7 but substantial release 
after exposure to pH 12.4 for 1.5 hours (Figure 12). 
 
 
Figure 11. UV/Vis spectra for release of Hb at pH 7 and pH 12.4. Release of Hb from sol-gel films 
was determined by measuring the OD of bathing buffer at 405nm over different time intervals and 
correlated to % release. 
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Figure 12. UV/Vis spectra for release of Mb from sol-gel films. Release of Mb from 
sol-gel films was determined by measuring the OD of bathing buffer at 407nm over 
different time intervals. 
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Release profiles of proteins were tested at various conditions of temperatures and ionic strength 
of buffers, and long term storage. The concentration of bathing buffer (5mM-500mM) and 
temperature (4
o
C-60
o
C) had negligible effect on immediate release of Hb and Mb proteins. When 
exposed to very high temperatures for extended periods of time there was only about 0.5% 
release of Hb and about 2% release of Mb from the sol-gel films. Short term storage (1 day to 1 
week) or Long Term Storage of sol-gels (1 week to 2 months) does not show any release of 
encapsulated proteins into the buffer. 
The release of a small molecule, the potential anticancer drug Distamycin A ( also discussed in 
Chapter 6) from sol-gel films was tested at pH 7 and pH 12 (Figure 13). Distamycin A was 
encapsulated inside sol-gel films using the standard protocol for making sol-gel films and release 
into bathing buffer was tested by UV/Vis spectroscopy to see characteristic peak at 303nm. It is 
seen that the release of small molecules is also higher at alkaline conditions.  
 
 
 
 
 
 
 
Figure 13. Release of small molecule Distamycin A from sol-
gel films. Release of Distamycin A was determined by 
measuring O.D of bathing buffer at 303nm. The O.D was 
correlated to % release over time.  
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The sol-gel matrix seems to degrade at alkaline pH conditions. This conclusion is supported by 
the observation that sol-gel films tend to thin down after exposure to basic buffer and is 
completely degraded/diminished after bathing in this buffer for 2-3 days. Moreover when 
nanogels were synthesized from these films and suspended in pH 12 buffer, the effective 
diameter measured using DLS decreased over time and the diameter was close to zero in a period 
of 2 hours (Table 5). Similar degradation of particles was noticed in nanogels produced from 
both Lyophilization and Polylysine protocols.  
 
                     Table 5. Effective diameters of nanogels exposed to basic conditions over a function of time.                                                       
                     The size of the nanogels decreases with increasing exposure time to pH 12 phosphate buffer. 
 
 
 
 
The effect of concentration (5mM-500mM) and temperature (10
o
C-35
o
C) was found to have 
negligible difference on release patterns in a period of 2 hours. Higher temperature of about 52
o
C 
does not show any release of encapsulated protein immediately, however continuous exposure 
for about 60 minutes to high temperature shows only 0.5% release of Hb and approximately 2% 
release of Mb from sol-gel films. A slightly higher % release of Mb is expected in comparison to 
Hb (over extended periods of time) because of the comparatively smaller size of Mb.   
 
 
Time (min) of exposure of 
nanogels to pH 12 buffer 
Effective Diameter (nm) 
0 360 
60 18 
120 8 
140 0 
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Conclusions 
After analysis of the nanogels resulting from two different approaches (Polylysine and 
Lyophilization) it was concluded that the particle size of polylysine precipitated nanogels have a 
wider size distribution of 300-500nm whereas particles synthesized using the lyophilization 
protocol have a size ranging from 50nm -100nm. Nanogels synthesized from polylysine protocol 
have a tendency to aggregate rapidly as seen from DLS studies and TEM studies. Although 
macromolecules can be easily encapsulated inside these nanogels, they rapidly diffuse out of the 
seemingly porous matrix of these particles. In comparison nanogels synthesized using 
Lyophilization protocol are much more stable with regard to aggregation and shows greater 
colloidal stability (indicated by the zeta potential of -30mV) as well as better encapsulation 
(entrapment inside the matrix) of macromolecules.  Proteins such as Hb do not diffuse out of the 
sol-gel matrix under most working/biologically relevant conditions. In spite of being confined to 
the sol-gel matrix the protein remains active and functional (as shown from studies described in 
later chapters). Moreover the degradation of the sol-gel matrix at alkaline conditions can be 
further evaluated for potential therapeutic advantage for delivery of encapsulated molecules for 
various applications.  
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Synthesis of nanogels using different precipitating agents  
Synthesis of silica nanoparticles utilizing cationic precipitating peptides such as R5 isolated from 
Diatoms have been studied earlier [6,8] and showed potential for development for various 
applications. We explored this biomimetic approach, using the polycationic silica precipitating 
agent Polylysine and then expanded it to other cationic agents such as Lysine, Arginine and 
Histidine. All the nanoparticles were synthesized using the standard polycationic peptide 
protocol using equivalent concentrations of precipitating peptides (10mg/ml). The resultant 
nanogels size was determined using DLS measurements (Brookhaven Instruments Corporation 
BIC) and TEM micrographs (JEOL, model JEM-1200 EX).  
Results 
The resulting sol-gel based nanoparticles using Lysine gave a smaller average size of 100-300 
nm as compared to a larger size of 300-500 nm when using PLL based nanogels. Particles 
produced using Arginine have similar size distribution to that of Lysine (100-300 nm), yet 
display a lower colloidal stability and low uniformity with high aggregation tendencies. The use 
of Histidine for silica precipitation did not provide any defined shapes and showed high 
aggregation tendencies (Table 6 and Figure 14). 
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                         Table 6. Differences between nanogels synthesized from different precipitating agents 
    
 
 
 
 
  
 
 
Precipitating agent  Observation  
Polylysine  Circular uniformly dispersed nanogels.  
Size: 300-500 nm.  
Lysine  Circular shape. Smaller in size as compared to Polylysine.  
Size: 100-300 nm. Aggregates readily. Low colloidal stability.  
Arginine  Not as uniformly circular, smaller in size as compared to 
Polylysine. Size: 100-300 nm. Aggregates readily. Low colloidal 
stability.  
Histidine  No defined shapes formed. High aggregation.  
2µm 
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Figure 14. a. Nanoparticles made by polylysine 
Average Size: 400nm, Scale Bar: 500 nm; b. 
Nanoparticles made by Lysine, Average Size: 100nm, 
Scale Bar: 2µm; c. Nanoparticles made by Arginine, 
Average Size: 100nm -300 nm, Scale Bar: 500 nm. 
 
a b 
c 500 nm 
2 µm 
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Conclusions  
Precipitation of nanogels using cationic peptides other than polylysine resulted in smaller sizes 
(arginine and lysine), although over long periods of time they show low colloidal stability. 
Monomeric cationic amino acids are able to produce particles and offer an economic advantage 
over longer chain polypeptides. Use of arginine and poly-arginine as precipitating agents is of 
much interest as this approach may offer a potential therapeutic advantage due to polyarginine’s 
well-known cell penetrating properties for drug delivery [11-14]. 
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CHAPTER 4 
SURFACE MODIFICATION AND PEG DECORATION OF 
NANOGELS 
In various studies it has been sometimes found that, after synthesizing nanoparticles, aggregation 
among particles took place when they were re-suspended in an aqueous solution, because the 
suspended silica particles formed agglomerates, probably due to (interparticle) hydrogen bonding 
[15]. Steric hindrances, by the use of polymers (steric stabilizers) adsorbed or grafted onto 
particle surfaces, have been one answer to the problems posed by aggregations among particles 
in an aqueous suspension. In this case, direct contacts among particles are prevented by the 
polymer chains extending into the medium. Therefore, aggregation of particles will not be 
formed, or the rate of coagulation will be decreased, depending on the degree of coverage of 
polymers on the particles and the thickness of the polymer layer [16-18]. We have used 
polyethylene glycol (PEG) to coat our nanogels (Figure 15). PEG acts as a steric stabilizer, its 
polymeric polyethylene chains extend far into the surrounding medium. Thus, in an aqueous 
suspension, the aggregation among the nanoparticles is prevented by the repulsion force and 
solvation layer of the PEG surface moiety [19]. Some other important advantages of having PEG 
coatings on the silica nanoparticles are due to their applications inside biological samples. PEG 
is nontoxic, and its attachment to silica nanoparticles provides a biocompatible and protective 
surface [20]. Also, the PEG coatings reduce protein and cell adsorption onto the particles and can 
reduce the rate of clearance of PEG coated materials, hence increasing the particle circulation 
time in bodily fluids for in vivo applications [21]. 
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PROCEDURE  
Synthesis of PEG coated nanogels  
TMOS was hydrolyzed by adding 2mM HCl (2:1 ratio) and sonicated for 30 minutes.   Desired 
concentration of PEG 400 was added to 50mM phosphate buffer pH 7. The buffer/PEG mixture 
was added to the hydrolyzed TMOS (1:1 ratio) and mixed. The solution formed uniform gels in 
30 seconds to 1 minute. The casted gel was washed with buffer 3 times.  
To make nanogels, the sol-gel films were slightly crushed using a spatula and dried at room 
temperature for 12 hours and lyophilized for 5 hours (LABCONCO, freezone). 
Dynamic Light Scattering and Zeta Potential Analysis  
DLS measurements were performed on a 90 plus particle size analyzer (Brookhaven Instruments 
Corporation) employing a 90° scattering angle and a 35 mW incident laser (658 nm). Small 
amounts of nanogels (1-2mg) were suspended in deionized water and sonicated for 15 minutes 
before taking measurements. The reported diameter is the average of 5 runs for each sample. 
Zeta Potential measurements were done by adding small amount (1-2mg) of nanogels in 1mM 
KCl solution and sonication for 15 minutes. (Brookhaven Instruments Inc. Zeta Plus). 
 
 
PEG  
Figure 15. General structure of Polyethylene  Glycol (PEG). 
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Transmission Electron Microscope Studies 
Dilute samples used for DLS measurements were mixed in a 1:1 ratio with 1% uranyl acetate, 
sonicated for 10 minutes. Then 5ul was put on a carbon film coated copper grid, 300 mesh 
(electron microscopy sciences, Hatfield, PA) and the excess solution was removed immediately 
using absorbent paper. The grids were dried overnight and viewed under the transmission 
electron microscope (JEOL, model JEM-1200 EX). Images were taken with a SIA–L3C CCD 
camera (Scientific Instruments and Applications, Inc.) using the software Maxim DL5 
(Diffraction Limited, Ottawa, Canada). 
 
Fourier Transform Infrared Spectroscopy (FTIR) Studies  
Evidence of the PEG coating was given by FTIR spectra of the dried nanogel particles, recorded 
by a FTIR-8400S Shimadzu. The samples were prepared by mixing the pure PEG polymers or 
nanogels with KBr by grinding, and then placed some of the powder mixture into a metal mount 
to form a pellet in the mount by applying pressure to both ends. The prepared mount was then 
placed into the FTIR system, for analysis. 
 
Rhodamine-PEG binding tests using UV Visible Spectroscopy  
Control nanogels were prepared using standard Lyophilization protocol (given in Chapter 2). 
Synthesized control nanogels were incubated in a solution of Rhodamine-PEG 5000 (Nanocs 
Inc.). The nanogels were spun down using a centrifuge at periodic intervals and UV Visible 
spectra of the supernatant was taken using Shimadzu UV-2450. 
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Results - PEG incorporation within nanogels.  
 
 
Pure silica particles possess characteristic peaks at 796, 950, 1065, 1400, 1633, and 3400 cm 
-1
. 
Most of the peaks associated with PEG are obscured by overlapping peaks of the pure silica  
Figure 16. FTIR spectra of a. pure sol-gel nanoparticles, b. pure PEG 400, c. sol-gel nanoparticles modified 
with 1% v/v PEG 400, d. sol-gel nanoparticles modified with 2.5% PEG 400, e. sol-gel nanoparticles with 5% 
PEG 400, f. sol-gel nanoparticles with 10% PEG 400. The spectrum of PEGylated sol-gel nanoparticles shows 
a new absorption peak at 2882 cm
-1
, corresponding to one of the characteristic peaks of PEG 400. These peaks 
suggest the binding of PEG to the silica particles. 
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nanoparticles. However the spectrum of PEGylated sol-gel nanoparticles (Fig. 16(c-f)) shows a 
new absorption peak at 2882 cm
-1
, corresponding to one of the characteristic peaks of PEG 400.  
These peaks suggest the binding of PEG to the silica particles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
TEM micrographs showed that the PEG encapsulated nanoparticles are more stable over time. 
After storage for 2 days without disturbance the particles with PEG were more uniformly 
distributed and disaggregated as compared to nanogels without PEG (Figure 17).  
 
 
 
 
Figure 17. TEM micrographs of a. aggregated nanogels (no PEG) which were stored for 2 days, 
Scale Bar: 1µm; b. nanogels with PEG incorporated inside which were stored for 2 days, Scale 
Bar: 1µm. 
1µm 1µm 
a b 
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PEG Binding Tests 
The binding of PEG to the surface of nanogels was investigated by incubating control nanogels 
with a solution of Rhodamine-PEG 5000 adduct (Nanocs inc).  (Illustration shown below). 
Rhodamine-PEG 5000 adduct solution was incubated with nanoparticles for 2 hours and the 
solution was centrifuged away from the nanogel particles and the O.D of the supernatant (at 
characteristic wavelength of 558 nm) taken at different time intervals was measured (Figure 18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Centrifuge  
Separate supernatant and 
measure in UV/Vis 
spectrophotometer 
Nanogel pellet left at the 
bottom with attached 
Rhodamine PEG  
 
 
Figure 18. Rhodamine-PEG 5000 adduct solution was incubated with nanoparticles for 2 hours and the solution 
was centrifuged away from the nanogel particles. Pictures of a. nanogel with Rhodamine PEG 5000 adduct 
mixed in the buffer; b. spun down nanogels incubated with Rhodamine PEG 5000 adduct for 2 hours. 
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As seen in Figure 19, the decrease in O.D at 558nm shows that approx. 50% of the Rhodamine-
PEG adduct was bound to the surface of the particles after 2 hours. After continuous washing the 
PEG Rhodamine adduct is still bound to the surface of nanogels indicating that PEG gets 
adsorbed to the surface of the nanogels.  
 
PEG binding tests using Sol-Gel Blocks 
 
Sol-gel blocks were made by mixing hydrolyzed TMOS (with 2mM HCl) and 50mM pH 7 
phosphate buffer using standard protocol. The gels were molded in glass vials, washed 3 times 
with buffer and allowed to stand for 12 hours to age. Equivalent concentrations of Rhodamine B 
and Rhodamine- PEG adducts were added to the top surface of two separate sol-gel blocks  and 
diffusion of added solutions into the gel was observed periodically over a period of 2 hours. 
Figure 19. UV/Vis spectra of supernatant from Rhodamine-PEG nanogels. 
Rhodamine-PEG adduct solution was incubated with nanogels for 2 hours 
and the solution was centrifuged away from the nanogel particles and the 
O.D of the supernatant (at characteristic wavelength of 558nm) taken at 
different time intervals was measured. After continuous washing 
approximately 50% of the PEG-Rhodamine adduct is still bound to the 
surface of nanogels indicating that PEG gets adsorbed to the surface of the 
nanogels. 
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Figure 20. a. pure sol-gel with buffer; b. sol-gel with Rhodamine dye and Rhodamine PEG-5000 mixed in the 
buffer; c. sol-gel after 2 hours d. sol -gel after 2 hours inverted view; e. sol-gel after 2 hours slanted view. After 
2 hours of incubation of sol-gel blocks I and II with Rhodamine dye and Rhodamine–PEG adduct respectively, 
Rhodamine dye almost completely diffuses inside the sol-gel whereas the Rhodamine-PEG adduct stays mostly 
at the surface of the sol-gel. 
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As can be seen in Figure 20, after 2 hours of incubation of sol-gel blocks I and II with 
Rhodamine dye and Rhodamine–PEG adduct respectively, Rhodamine dye almost completely 
diffuses inside the sol-gel whereas the Rhodamine-PEG adduct stays mostly at the surface of the 
sol-gel. The Rhodamine PEG adduct is also not seen in the buffer on top of the sol-gel, as 
compared to the Rhodamine dye which is evenly distributed throughout the sol-gel and the buffer 
on top of it. This indicates that PEG binds to the surface of sol-gel and does not diffuse inside.  
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SURFACE MODIFICATION OF NANOGELS USING PHOSPHONATE AND AMINE 
GROUPS.  
Surface modification of nanogels was done to reduce aggregation of particles and to also provide 
linking groups on the surface of the nanogels for attachment of different therapeutic ligands. 
When amine and phosphonate groups are present on the surface of particles there is an 
elimination of back bonding due to interactions between the amine and phosphonate groups on 
the particle surface, thus increasing the shear plane and electrostatic repulsion of the particles. 
Amine groups can be attached using 3-Amino propyl triethoxy silane (APTES) and phosphonate 
groups by using 3 -(trihydroxysilyl) propyl methyl phosphonate (THPMP) (Figure 21) [22].  
 
Figure 21. a. Attachment of APTES; b. Attachment of APTES and THPMP to nanogels.  When amine and 
phosphonate groups are present on the surface of particles there is an elimination of back bonding due to 
interactions between the amine and phosphonate groups on the particle surface, thus increasing the shear 
plane and electrostatic repulsion of the particles [Bagwe et al., 2006]. 
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Procedure  
A mixture of APTES, THPMP and TMOS in ethanol was sonicated for 20 minutes. The resulting 
hydrolyzed TMOS solution containing the different organosilane groups was mixed with 50mM  
pH 7 phosphate buffer in a 1:1 ratio. This solution gelled within 1 minute. The resulting sol-gel 
was dried for 24 hours and lyophilized for 5 hours resulting in modified nanogels (Figure 22). 
The modified nanogels were tested for size (DLS) and zeta potential to evaluate their colloidal 
stability.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Synthesis of APTES 
and THPMP modified nanogels. 
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Results  
The size of particles as seen from the DLS measurements (Figure 23) increased with increasing 
concentrations of amine groups (APTES) and decreased with increasing concentrations of 
phosphonate groups (THPMP).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Effect of increasing amine and phosphonate modification on particle diameter of nanogels. The 
size of particles as seen from the DLS measurements increased with increasing concentrations of amine 
groups (APTES) and decreased with increasing concentrations of phosphonate groups (THPMP). 
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The zeta potential of the particles increases and becomes less negative with increasing amine 
concentration (APTES) showing less colloidal stability. On the other hand the zeta potential 
becomes increasingly negative with increase in phosphonate concentration (THPMP) suggesting 
higher colloidal stability (Figure 24).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Effect of increasing amine and phosphonate modification on zeta potential of nanogels. The zeta 
potential of the particles increases and becomes less negative with increasing amine concentration (APTES) 
showing less colloidal stability. Zeta potential becomes increasingly negative with increase in phosphonate 
concentration (THPMP) suggesting higher colloidal stability. 
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Conclusions 
Our studies on surface modification of nanogels using linkers like PEG, APTES and THPMP 
suggest that the surface of particles can be modified to improve the properties of these nanogels 
such as aggregation, and linkage to other groups to improve targeting. Furthermore these 
modifications can be performed using mild approaches (room temperature and physiological pH) 
so as not to affect the nature of the encapsulated molecules.  
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CHAPTER 5 
SOL-GEL AND NANOGEL ENCAPSULATION OF 
MACROMOLECULES 
 
Biological agents can be incorporated inside the sol-gel network and nanogels due to its unique 
favorable properties towards proteins and enzymes. Here we have incorporated different 
macromolecules inside the sol-gel and nanogel matrices and tested if the proteins are intact and 
functional.  
Incorporation of Hemoglobin inside sol-gels and nanogels.  
Hemoglobin (Hb) is an iron-containing oxygen-transport metalloprotein in the red blood cells of 
most vertebrates as well as the tissues of some invertebrates. Hemoglobin in the blood carries 
oxygen from the respiratory organs (lungs or gills) to the rest of the body (i.e. the tissues) where 
it releases the oxygen for providing energy to power the functions of the organism in the process 
called metabolism [23,24]. 
In most vertebrates, the hemoglobin molecule is an assembly of four globular protein subunits. 
Each subunit is composed of a protein chain tightly associated with a non-protein heme group 
(Figure 25). A heme group consists of an iron (Fe) ion held in a heterocyclic ring, known as a 
porphyrin. 
In adult humans, the most common hemoglobin type is a tetramer (which contains 4 subunit 
proteins) called hemoglobin A (Figure 25), consisting of two α and two β subunits non-
covalently bound, each made of 141 and 146 amino acid residues, respectively. This is denoted 
as α2β2. The subunits are structurally similar and about the same size. Each subunit has a 
molecular weight of about 16,000 Daltons, for a total molecular weight of the tetramer of about 
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64,000 Daltons. Hemoglobin A is the most intensively studied of the hemoglobin molecules [24-
26]. 
 
 
 
 
 
 
The iron ion may be either in the Fe
2+
 or in the Fe
3+
 state, but ferrihemoglobin (methemoglobin) 
(Fe
3+
) cannot bind oxygen. While binding, oxygen temporarily and reversibly oxidizes (Fe
2+
) to 
(Fe
3+
), oxygen temporarily turns into superoxide, thus iron must exist in the +2 oxidation state to 
bind oxygen. If superoxide ion associated to Fe
3+
 is protonated, the hemoglobin iron will remain 
oxidized and incapable of binding oxygen. In such cases, the enzyme methemoglobin reductase 
will be able to eventually reactivate methemoglobin by reducing the iron center. 
It is known that methemoglobin (iron is in 3+, ferric state) absorbs at 405nm. In this state the 
hemoglobin cannot bind oxygen. Deoxyhemoglobin (+2 ferrous state) absorbs at 430 nm, this is 
not bound to oxygen but it can when exposed to oxygen. Oxyhemoglobin (+2 ferrous state) 
absorbs at 415nm. This is when Hb is bound to oxygen. Hemoglobin can shift between different 
ligation and oxidation states depending on the environment it is exposed to and this property is 
vital for it to perform its function in the body [25-27]. 
Figure 25. a. Structure of human hemoglobin. The proteins' α and β subunits are in red 
and blue, and the iron-containing heme groups in green; b. Structure of Heme b group. 
a b 
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In this study Met-Hemoglobin was incorporated inside nanogels and sol-gel films using the 
standard protocol for nanogels and sol-gel synthesis.  To these nanogels and sol-gel films and 
nanogels, sodium dithionite (DTT) (a reducing agent) was added to change the oxidation state 
and further the nanogels were exposed to oxygen to change the ligation state. 
The position of the absorbance peak due to the HEME changes under different ligation states and 
oxidation states showing that the protein is functional inside the nanogels and the sol- gel film 
(Figure 26). It is seen that encapsulated Met-Hb starts out with an absorbance peak at 405nm, 
which shifts to 430 nm after addition of DTT (which changes iron from +3 to +2 oxidation state). 
Upon exposure to oxygen the peak returns to 415nm indicating the binding of oxygen and 
conversion to oxy-hemoglobin.  
These results also show that the diffusion into the sol-gel is very efficient and that water and 
added small molecules (such as DTT) can reach the encapsulated protein. 
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Figure 26. UV/Vis spectra of Hemoglobin in solution, encapsulated inside sol-gel films, and 
nanogels. It is seen that encapsulated Met-Hb starts out with an absorbance peak at 405nm, which 
shifts to 430 nm after addition of dithionite (which changes iron from +3 to +2 oxidation state). 
Upon exposure to oxygen the peak returns to 415 nm indicating the binding of oxygen and 
conversion to oxy-hemoglobin. The position of the absorbance peak due to the HEME changes 
under different ligation states and oxidation states showing that the protein is functional inside the 
nanogels and the sol-gel film. 
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Incorporation of Glucose Oxidase 
The glucose oxidase enzyme (GOx) is an oxido-reductase that catalyzes the oxidation of glucose 
to hydrogen peroxide (H2O2) and D-glucono-δ-lactone [28,29]. 
 
 
In cells, it helps in breaking sugar down into its metabolites. Glucose oxidase (often extracted 
from Aspergillus niger) is widely used for the determination of free glucose in body fluids 
(diagnostics), in vegetal raw material, and in the food industry. It also has many applications in 
biotechnology, typically enzyme assays for biochemistry including biosensors in nanotechnology 
[28-31]. 
GOx was incorporated inside the nanogels using our standard protocol for synthesis of nanogels 
(Figure 27).  
 
 
 
 
 
 
 
 
 
 
 
 
β-d-glucose + O
2
 
Glucose Oxidase  
hydrogen peroxide + d-glucono-β-lactone 
TMOS soln. 
(2mM HCl + TMOS)  
50 mM Phosphate 
Buffer pH 7 + GOx 
Sol-Gel containing 
GOx 
Dried and 
Lyophilized for 5hrs 
GOx encapsulated 
nanogels.  
Figure 27. Synthesis of GOx encapsulated nanogels 
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The presence of GOx inside the sol-gel film was confirmed by checking characteristic 
protein UV/Vis peak at 280nm (Figure 28). 
 
 
 
 
 
 
 
 
 
 
 
 
The activity of GOx encapsulated inside the synthesized nanogels was tested by exposing the 
nanogels to glucose and using an iodide assay for determination of H2O2 (measured 
spectroscopically at 352nm).  
The sample containing hydrogen peroxide was mixed with Reagent A (6.5 g KI and 0.5 g 
NaOH and 0.05 g ammonium molybdate in 250 mL water,  final pH 11) and  Reagent  B (5 g 
biphthalate in 250 mL water, the pH should be 4) in a 1:5:5 ratio. The mixture was allowed to 
develop color for 5 minutes before taking UV/Visible Spectra.  
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Figure 28. UV/Vis spectra of Glucose Oxidase nanogels. The spectra shows characteristic protein 
peak at 280 nm suggesting that the GOx was encapsulated inside the nanogels.  
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Our studies have showed that GOx when encapsulated inside the sol-gel matrix is functionally 
active and is able to generate H2O2 when it is exposed to 0.3 M glucose (Figure 29). 
 
 
 
 
 
 
 
 
 
 
 
When the release rates of nanogels and sol-gel films were compared to that in solution with 
equivalent final concentrations of GOx (Figure 30), it was seen that GOx nanogels had the 
lowest rate with 18.6 µM/min and the sol-gel films had a slightly higher H2O2 release rate of 
23.1 µM/min. The rate in solution is highest (37.9 uM/min) when compared to both nanogels 
and sol-gels. The observation may be attributed to the fact that it takes more time for the 
dextrose to diffuse into the sol-gel and nanogels and react with the entrapped enzyme and 
there is also a delay in the release of H2O2 produced as a result of the reaction. 
 
 
 
 
Figure 29. Continuous release of H2O2 from GOx encapsulated nanogels when 
exposed to 0.3 M Glucose. The nanogels were exposed to bathing buffer containing 
glucose. The concentration of H2O2 was determined by using an iodide assay for 
determination of H2O2 (measured spectroscopically at 352 nm).   The rate of formation 
of H2O2 is 23.5 µM/min. 
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 Both the sol-gel and nanogels were actively producing H2O2 after a week of storage.  
These results indicate that the sol-gel and nanogel network is capable of holding the protein 
intact inside without adversely affecting its biological function.  
 
Sol-gel Incorporation of Transferrin  
Transferrins are iron-binding blood plasma glycoproteins that control the level of free iron in 
biological fluids. Transferrin glycoproteins bind iron very tightly, but reversibly. Transferrin 
has a molecular weight of around 80 KDa and contains two specific high-affinity Fe(III) 
binding sites [32]. The affinity of transferrin for Fe(III) is extremely high at pH 7.4 but 
decreases progressively with decreasing pH below neutrality. When not bound to iron, it is 
known as "apotransferrin" [33]. 
Transferrin has various roles in diseases and is therefore of great interest to scientists for 
therapeutic purposes. An increased plasma transferrin level is often seen in patients suffering 
Figure 30. Comparison of H2O2 release from nanogels, sol-gel films and solution. All 
three samples were exposed to equivalent concentrations of glucose and H2O2 
generation was measured using an iodide assay for determination of H2O2 (measured 
spectroscopically at 352nm).  
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from iron deficiency anemia. A decreased plasma transferrin can occur in iron overload 
diseases and protein malnutrition. An absence of transferrin results from a rare genetic 
disorder known as atransferrinemia; a condition characterized by anemia and hemosiderosis 
in the heart and liver that leads to many complications, including heart failure [34-36]. 
Transferrin is also associated with the innate immune system. It is found in the mucosa and 
binds iron, thus creating an environment low in free iron that impedes bacterial survival in a 
process called iron withholding. The level of transferrin decreases in inflammation [37]. 
Most recently, transferrin and its receptor have been shown to diminish tumour cells by using 
the receptor to attract antibodies [35, 38-40]. 
We have incorporated Transferrin inside sol-gel films and tested its function and stability 
utilizing a Phenanthroline assay for iron determination. 1, 10-Phenanthroline reacts with Fe
2+
 
to form a characteristic orange-colored complex (Figure 31). The intensity of color 
development is directly proportional to the amount of Fe
2+ 
in the sample which can be 
measured at 510 nm. 
 
 
 
 
 
Figure 31. Chemical reaction of 1, 10-Phenanthroline used for iron determination. Ferrous ions 
react with 1, 10 Phenanthroline to form an orange colored complex with a characteristic OD at 
510 nm. 
3 phen + Fe 
2+
 ----------------> Fe(phen)
3
2+
 
2+ 
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Procedure  
Transferrin encapsulated sol-gel films were prepared using the standard protocol for sol-gel 
films. The films were exposed to 50 mM pH 3 citric acid-phosphate buffer for 1 day. The 
bathing buffer was separated and mixed with 10% v/v Hydroxylamine HCl and 0.3% w/v 1, 
10 Phenanthroline in 5:1:1 ratio. Hydroxylamine serves to reduce the ferric ion to ferrous ion 
which can then react with 1,10 Phenanthroline and form the colored complex. The solution 
was allowed to mix for 5 minutes and the O.D at 510 nm was measured using a diode array 
UV Visible spectrophotometer (Agilent) (Figure 32).  
 
The results showed that the iron held by the transferrin encapsulated inside the sol-gel is released 
after exposure to low pH indicating that the transferrin is functionally active even after 
entrapment inside the sol-gel matrix (Figure 33).  
Figure 32. Phenanthroline assay for iron release test. The sol-gel film encapsulating the apotransferrin was bathed 
with 50mM pH 3 buffer. The bathing buffer was separated and mixed with 10% v/v Hydroxylamine HCl and 0.3% 
w/v 1, 10 Phenanthroline in 5:1:1 ratio. Hydroxylamine serves to reduce the ferric ion to ferrous ion which can then 
react with 1,10 Phenanthroline and form the colored complex. The solution was allowed to mix for 5 minutes and 
the OD at 510 nm was measured using a diode array UV -Visible spectrophotometer. 
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Figure 33. The release of iron from transferrin encapsulated inside sol-gel film when exposed to low pH, tested by 
Phenanthroline assay using spectroscopic measurement at 510nm. 
A similar experiment was done with nanogels incorporated with transferrin. In a period of 2 
hours of exposure to low pH almost all the iron was released from the transferrin entrapped 
inside the nanogels (Figure 34).  
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Figure 34. The release of iron from transferrin encapsulated inside nanogels when exposed to low pH,                  
tested by Phenanthroline assay using spectroscopic measurement at 510 nm. 
 
Compatibility of transferrin with the sol-gel matrix is promising because transferrin can be used 
in drug delivery as a conjugation linker to stabilize and improve the pharmacokinetics of certain 
therapeutically-important biomolecules. It efficiently transports these biomolecules and links 
with key cell receptors, providing intracellular delivery. Use of Transferrin with biodegradable 
nanoparticles such as ours gives rise to possibilities for various therapeutic applications 
exploiting the unique advantages of nanogels.  
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Conclusions  
Fabrication of nanogels with macromolecules encapsulated within was achieved. There was no 
significant difference of nanogel properties with or without the encapsulated proteins. In spite of 
being confined to the sol-gel matrix, incorporated proteins are active and functional. Their small 
molecule substrate and products however can diffuse in and out of the sol-gel matrix. These 
results suggest that nanogels are an optimal choice for a macromolecule carrier matrix.  
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CHAPTER 6 
SOL-GEL AND NANOGEL ENCAPSULATION OF SMALL 
MOLECULES 
 
Application of various nanoparticles for the delivery of small therapeutic agents is still being 
explored by scientists and a lot of work needs to be done in the characterization and safety of 
nanoparticles being studied. Nanogels are suitable carriers for delivery of small molecules due to 
their properties. We have synthesized small molecule encapsulated nanogels by utilizing a very 
simple technique of trapping the drugs inside the nanogel network while the particles are being 
synthesized. The solgel network is able to encapsulate various kinds of drugs such as Ampicllin, 
Kanamycin, Thyoquinone and Distamycin A (Figure 35). Our release studies have shown that 
drugs are diffused out of the nanogel pores readily because of their small size. 
 
 
 
 
 
 
 
 
 
 
 
a b 
c d 
Figure 35. Structure of a. Ampicllin, b. Kanamycin, c. Thymoquinone, d. Distamycin A. 
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Bacterial cell survival studies were performed using the synthesized antibiotic encapsulated 
nanogels using the following procedure.  
Procedure for Bacterial Cell survival studies  
E. coli was grown aerobically at 37°C for 12-16 h with shaking (250 rpm) in Luria-Bertani 
medium (LB). The saturated cultures were diluted in fresh LB medium starting at (OD 600 ) 0.05 
(optical density) and incubated at 37 °C in Erlenmeyer flasks with vigorous shaking at 250 rpm 
as well until they reached a concentration of 2x 10
5 
cells/ml. Each E.coli solution was incubated 
with different nanogels for a total time of 90 minutes. Four dilutions were made at each time 
interval and three 20 ul drops were plated from each dilution on solid agar plates. Plates were 
incubated overnight at 37
o
 C and colonies counted. All results were compared to the control 
without any nanogels (Figure 36).  
 
 
 
 
 
 
 
 
 
Number of colonies (n) plate x reciprocal of dilution of sample (1/D) = number of bacteria /ml 
in the reaction mixture for a given time point. 
n  
= D 
For each time 
point the 
concentration 
of cells was 
determined by 
taking a sample 
of known 
volume from 
the original 
inoculum and 
preparing serial 
dilutions. 
 
Figure 36. Illustration for bacterial cell survival studies of nanogels. An original inoculum of bacteria is 
incubated with samples being tested. For each time point the concentration of cells is determined by taking a 
sample of known volume from the original inoculum and preparing serial dilutions at different time points 
and plating for kinetic study. Number of bacteria at a given time point is calculated by multiplying no. of 
surviving colonies on plates by the reciprocal of dilution of samples.  
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Synthesis of Kanamycin Encapsulated nanogels and testing on E.coli.  
Kanamycin is an aminoglycoside bactericidal antibiotic isolated from the bacterium 
Streptomyces kanamyceticus, and is used to treat a wide variety of infections [41].  
Kanamycin interacts with the 30S subunit of prokaryotic ribosomes. It induces substantial 
amounts of mistranslation and indirectly inhibits translocation during protein synthesis [42, 43]. 
We have incorporated Kanamycin inside nanogels and tested their effect on E.coli bacterial cells. 
The following method was used to prepare Kanamycin encapsulated nanogels: 
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 30 minutes (2TMOS: 1HCl). 
Kanamycin sulfate (Gibco) was mixed in potassium phosphate buffer pH 7, 50mM. This solution 
was added to the hydrolyzed TMOS solution (1:1 ratio). This resulted in sol-gel blocks and 
Kanamycin was incorporated inside the sol-gel matrix during gelation. The sol-gels produced 
were dried at room temperature for 12 hours, slightly crushed using a spatula and lyophilized for 
5 hours. (LABCONCO Free Zone 2.5). 
Equivalent amounts of control and kanamycin nanogels were taken to test in bacteria. Final 
concentration of Kanamycin in the samples tested was 50ug/ml.  
As seen in Figure 37, Control nanogels do not have adverse effects on the growth of bacteria, 
and Kanamycin encapsulated nanogels are able to deliver the antibiotic to the bacterial cells and 
demonstrate rapid killing.  
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Synthesis of Thymoquinone (TQ) encapsulated nanogels and testing on E.Coli 
Thymoquinone is a phytochemical compound found in the plant Nigella sativa. It is known to 
exhibit antioxidant, anti-inflammatory and anti- cancer effects and has been shown to protect 
against heart, liver and kidney damage in animal studies [44-46]. It has been shown to suppress 
the proliferation of various tumor cells, including colorectal carcinoma, breast adenocarcinoma, 
osteosarcoma, ovarian carcinoma, myeloblastic leukemia, and pancreatic carcinoma [47–52], 
while being minimally toxic to normal cells [53]. 
Most drugs, especially those with hydrophobic nature such as Thymoquinone, when examined in 
human clinical trials fail because of either lack of safety or due to poor efficacy which could be 
in part due to poor bioavailability. Although a lot of natural products have served as leads for the 
Figure 37. Effect of Kanamycin encapsulated nanogels on E.coli cell survival. Control nanogels do not have adverse 
effects on the growth of bacteria, and Kanamycin encapsulated nanogels are able to deliver the antibiotic to the 
bacterial cells and demonstrate rapid killing. 
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majority of drugs, poor oral bioavailability has hindered their development without a suitable 
carrier [54]. 
Encapsulation of such a molecule would enhance cytotoxicity based on developments in drug 
delivery and nanotechnology. 
We describe the design of biodegradable TQ encapsulated nanogels and characterize its effects 
on bacterial cell survival. We found that our sol-gel based technique and nontoxic synthesis 
method is compatible with a hydrophobic drug such as TQ, moreover TQ encapsulated nanogels 
are able to show antibacterial effect on E.coli cells. Successful results from these initial 
experiments opens ways for development of other hydrophobic plant based drugs using this 
technique.  
Procedure  
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 40 minutes, 2TMOS : 1HCl. 
Thymoquinone (Sigma Aldrich) was mixed in potassium phosphate buffer pH 7 50mM. This 
solution was added to the hydrolyzed TMOS solution (1:1 ratio) resulting in a sol-gel blocks. 
Thymoquinone was incorporated inside the sol-gel matrix during gelation. The sol-gels produced 
were dried at room temperature for 12 hours, slightly crushed using a spatula and lyophilized for 
5 hours (LABCONCO Free Zone 2.5). 
The encapsulation of Thymoquinone was tested by measuring the UV/Vis absorbance of 
synthesized nanoparticles at characteristic wavelength of 258nm (Figure 38).  Characteristic 
peak at 258nm confirmed the encapsulation of Thymoquinone inside the nanogels. The 
encapsulation is not 100% efficient, possibly due to the hydrophobic nature of the encapsulated 
drug, a portion of the drug may have released during washings of the nanogels.  
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         Figure 38. UV/Vis spectra of Thymoquinone encapsulated nanogels. Characteristic peak at 258 nm confirmed    
         the encapsulation of Thymoquinone inside the nanogels. 
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Equivalent amounts of control and Thymoquinone nanogels were taken to test in bacteria. Final 
conc. of Thymoquinone was 1mg/ml.  
As can be seen in Figure 39, the Thymoquinone encapsulated nanogels are able to show killing 
towards E.coli, and the control nanogels do not affect the growth of bacteria showing that the 
carrier itself is non-toxic to the microorganism.  
 
 
 
 
Figure 39. Effect of Thymoquinone encapsulated nanogels on bacterial cell survival. Thymoquinone encapsulated 
nanogels are able to show killing towards E.coli, and the control nanogels do not affect the growth of bacteria. 
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Synthesis of Ampicillin encapsulated nanogels and testing on E.coli. 
Ampicillin is an antibiotic useful for the treatment of a number of bacterial infections. It is a 
beta-lactam antibiotic that is part of the aminopenicillin family. Ampicillin has been used 
extensively to treat bacterial infections since 1961. Until the introduction of ampicillin by the 
British company Beecham, penicillin therapies had only been effective against Gram-positive 
organisms such as staphylococci and streptococci. Ampicillin also demonstrated activity against 
Gram-negative organisms such as H. influenzae, coliforms and Proteus spp. [55,56]. 
Ampicillin is able to penetrate Gram-positive and some Gram-negative bacteria. It differs from 
penicillin G, or benzylpenicillin, only by the presence of an amino group. That amino group 
helps the drug penetrate the outer membrane of Gram-negative bacteria [57]. 
Ampicillin acts as an irreversible inhibitor of the enzyme transpeptidase, which is needed by 
bacteria to make their cell walls. It inhibits the third and final stage of bacterial cell wall 
synthesis in binary fission, which ultimately leads to cell lysis [57-59]. 
Since the antibacterial properties of Ampicillin are very well known we have used the antibiotic 
to test the effect of our nanogels using E.coli bacterial cells.  
Ampicillin encapsulated nanogels were synthesized using the following procedure: 
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 40 minutes, 2TMOS: 1HCl. 
Ampicillin (Gibco) was mixed in potassium phosphate buffer pH 7 50mM. This solution was 
added to the hydrolyzed TMOS solution (1:1 ratio) resulting in a sol-gel blocks. Ampicillin was 
incorporated inside the sol-gel matrix during gelation. The sol-gels produced were dried at room 
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temperature for 12 hours, slightly crushed using a spatula and lyophilized for 5 hours. 
(LABCONCO Free Zone 2.5). 
Equivalent amounts of control and ampicillin nanogels were taken to test in bacteria. Final conc. 
of ampicillin was 100ug/ml.  
The bacterial studies (Figure 40) demonstrated the cytotoxicity of the ampicillin encapsulated 
towards E.coli cells.  
 
Figure 40. Effect of Ampicillin encapsulated nanogels on E.coli cell survival. Ampicillin encapsulated nanogels are 
able to show killing towards E.coli, and the control nanogels do not affect the growth of bacteria. 
 
Incorporation of Distamycin A in Sol-gel and Nanogels  
Distamycin A is an antibiotic produced by Streptomyces distallicus the structure of which was 
identified and confirmed by total synthesis by Arcamone et al. (1964). Partially purified 
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preparations of Distamycin A exerted an inhibitory action on the development of experimental 
tumors. The purified crystalline antibiotic shows antiviral activity on vaccinia and herpes 
simplex viruses in vitro or in experimental infections [60-64].  
Distamycin A encapsulated nanogels were synthesized using the following method: 
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 40 minutes, 2TMOS:1HCl. 
Distamycin A (Sigma Aldrich) was mixed in potassium phosphate buffer pH 7 50mM. This 
solution was added to the hydrolyzed TMOS solution (1:1 ratio) resulting in a sol-gel block. 
Distamycin A was incorporated inside the sol-gel matrix during gelation. The sol-gels produced 
were dried at room temperature for 12 hours, slightly crushed using a spatula and lyophilized for 
5 hours. (LABCONCO Free Zone 2.5) (Figure 41). 
 
 
 
 
 
 
 
 
 
 
 
Sol -Gel containing 
Distamycin A  
Dried and 
Lyophilized for5 
hours 
Nanogels with 
Distamycin A 
Figure 41. Illustration of synthesis of Distamycin A encapsulated nanogels. 
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The incorporation of Distamycin A inside the nanogels was tested by suspending the nanogels in 
buffer and checking the characteristic UV/ Visible absorbance of Distamycin at 303 nm  
(Figure 42). It was seen that Distamycin A was successfully encapsulated inside the nanogels. 
Distamycin A being a small molecule readily diffuses out of the nanogels (described in Chapter 
3). Nevertheless these studies indicate compatibility of various small molecules with nanogels 
which show promise for further development.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. UV/Vis Spectra of Distamycin A encapsulated nanogels. The spectra shows peak at 
characteristic wavelength 303 nm indicating encapsulation of Distamycin A inside nanogels.  
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SILVER NANOPARTICLE –SOL-GEL HYDRID NANOGELS 
Resistance of bacteria to bactericides and antibiotics has increased in recent years due to the 
development of resistant strains. Some antimicrobial agents are extremely irritant and toxic and 
there is much interest in finding ways to formulate new types of safe and cost-effective biocidal 
materials. Previous studies have shown that antimicrobial formulations in the form of 
nanoparticles could be used as effective bactericidal materials. It has been demonstrated that 
highly reactive metal oxide nanoparticles exhibit excellent biocidal action against Gram-positive 
and Gram-negative bacteria [65]. Thus, the synthesis and characterization of inorganic particles 
opens the possibility of formulation of a new generation of bactericidal materials. Various 
studies have indicated that silver ions and silver-based compounds are highly toxic to 
microorganisms showing strong biocidal effects on as many as 16 species of bacteria including 
E. coli [65-70]. Thus, silver ions, as an antibacterial component, have been used for various 
applications such as dental resin composites and ion exchange fibers and in coatings of medical 
devices [70-73]. The antibacterial activity of silver ions is well known and has been studied in 
detail. In 2004 Sondi and group have investigated the antibacterial activity of nontoxic 
elementary silver, in the form of nanoparticles and demonstrated the toxicity of silver towards 
bacteria [66]. 
In an effort to prepare a novel safe and nontoxic silver carrier, we have synthesized and 
characterized hybrid nanogels by incorporating silver nanoparticles inside sol-gel based 
nanoparticles.  
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PROCEDURE  
Synthesis of Silver Nanoparticles  
The solution containing Silver Nanoparticles was prepared in two steps. First 45mg of silver 
nitrate (AgNO3) was dissolved in 250mL of deionized water and heated slowly until the solution 
reached to 95-98 °C. In the second step, a 5ml of 1% (w/w) sodium citrate solution was made 
and added to the heated silver nitrate solution. This mixture was kept between 95 to 98 °C for an 
hour and product formation was evident when the mixture’s color changed to dark yellow-
greenish. After about 1 hour the solution was cooled slowly to room temperature. 
 
Synthesis of Silver nps –Sol-gel Hybrid nanogels  
Silver nanoparticle solution was mixed with 50mM pH 7 phosphate buffer in a 1:1 ratio. This 
mixture was added to hydrolyzed TMOS solution (1:1 ratio). After mixing uniformly the solution 
formed a sol-gel within 2 minutes. The film was dried at room temperature for 12 hours crushed 
and lyophilized for 5 hours resulting in hybrid nanogels (Figure 43). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOL-GEL  
SILVER NANOPARTICLES  
LYOPHILIZATION 
ENCAPSULATION OF SILVER 
NANOPARTICLES WITHIN 
NANOGELS 
Figure 43. Illustration for Synthesis of Silver nanoparticle - sol-gel hybrid nanogels. 
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The synthesized nanogels were characterized using Dynamic Light Scattering, UV/Visible 
Spectroscopy and Transmission Electron Microscopy.  
 
Silver nanoparticles as seen from TEM and DLS studies are about 50nm in size, they have good 
colloidal stability with a zeta potential of -50 mV. Encapsulation of silver nanoparticles inside 
the nanogels does not affect the original particle size and colloidal stability of the nanogels (as 
seen from the almost similar effective diameter and zeta potential values) (Table 7).  
 
 
 
 
 
 
 
 
 
Table 7. Effective Diameter and Zeta Potential of Synthesized Hybrid nanogels as characterized using DLS studies. 
Encapsulation of silver nanoparticles inside the nanogels does not affect the original particle size and colloidal 
stability of the nanogels.  
Sample  Effective Diameter (nm) Zeta Potential (mV) 
Silver Nanoparticles  50 -50 
Sol-gel nanoparticles (nanogels) 360 -30 
Silver Nanoparticles encapsulated in 
nanogels (Hybrid nanogels) 
370 -30 
76 
 
0.10
0.09
0.08
0.07
0.06
0.05
0.04
A
b
s
o
r
b
a
n
c
e
 
700650600550500450400350
Wavelength (nm)
 SolGel
 Buffer
 Sol Gel with silver 
        nanoparticles
The incorporation of silver nanoparticles inside the nanogel matrix was confirmed by UV/Visible 
spectroscopy of hybrid nanogels which shows characteristic peak of silver nanoparticles at 
420nm (Figure 44).  
 
 
 
 
                                                                     
 
 
 
 
 
 
 
 
 
 
 
Figure 44. The figure compares UV/Vis spectra of the hybrid nanogels (blue 
trace); of control nanogels that do not contain silver nanoparticles (red trace) and 
of the bathing buffer in which the hybrid nanogels were incubated for 24 hours 
and then separated (black trace). 
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Conclusions 
Various antibiotics were encapsulated inside the nanogels and tested on E.coli. The synthesized 
nanogels were able to kill bacterial cells indicating that encapsulated antibiotics are able to 
diffuse out from the nanogel matrix in a sustained manner and show therapeutic effect. Control 
nanogels without any antibiotic show no toxicity towards bacteria confirming the nontoxic 
properties of nanogel matrix offering a huge advantage as a carrier.  
Silver nanoparticles were encapsulated inside the nanogels resulting in hybrid nanogels which 
are stable and intact and do not change the properties of the nanogel matrix.   
Silver nanoparticles are known to have great potential for applications such as biosensors, 
biological tags for quantitative detection. They also have antibacterial applications and have been 
incorporated in apparel, footwear, paints, wound dressings, appliances, cosmetics, and plastics. 
Hybrid nanogels can provide additional benefits by acting as a nontoxic, inert carrier with 
sustained release from porous sol-gel matrix. Properties of sol-gel such as PEG binding, 
nonimmunogenic, surface decoration can be utilized if needed.   
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CHAPTER 7 
 
H2O2 AND NO DELIVERY USING NANOGELS 
A cell survival study on E.coli 
 
Nitric oxide (NO) is a short-lived, diatomic, lipophilic gas that plays an integral role in 
defending against pathogens. NO regulates a range of biological processes in the cardiovascular, 
gastrointestinal, genitourinary, respiratory, and central and peripheral nervous systems [74, 75]. 
Among its many functions are involvement in immune cell signaling and in the biochemical 
reactions by which immune cells defend against bacteria, fungi, viruses and parasites. NO 
signaling directs a broad spectrum of processes, including the differentiation, proliferation, and 
apoptosis of immune cells. Furthermore, the discoveries of NO as a vasodilator, antibacterial 
agent, and tumoricidal factor have made NO a promising pharmaceutical agent [74-78]. These 
observations led to the need for NO delivery systems that can harness its antimicrobial 
properties. A number of synthetic compounds that chemically store and release NO in a 
controlled fashion have been developed. Several classes of NO donors exist including 
nitrosothiols, nitrosamines, diazeniumdiolates, NO-metal complexes, and organic nitrites and 
nitrates [78,79].  
Sodium Nitroprusside (SNP) is one such NO donor. Nitroprusside is a complex anion that 
features an octahedral ferrous center surrounded by five tightly bound cyanide ligands and one 
linear nitric oxide ligand (Figure 45). SNP when exposed to light generates NO [79-82]. Since 
the sol-gel is a glass like transparent substance it is apt for encapsulation of photosensitive 
materials which can then be controlled to generate desired products.  
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The glucose oxidase enzyme (GOx) is an oxido-reductase that catalyzes the oxidation of 
glucose to hydrogen peroxide and D-glucono-δ-lactone. In cells, it helps in breaking sugar down 
into its metabolites. GOx (often extracted from Aspergillus niger) is widely used for the 
determination of free glucose in body fluids (diagnostics), in vegetal raw material, and in the 
food industry. It also has many applications in biotechnology, typically enzyme assays for 
biochemistry including biosensors in nanotechnology [28]. 
 
Our studies have showed (Chapter 5) that GOx when encapsulated inside the sol-gel 
matrix is functionally active and is able to generate H2O2 when glucose is provided. The 
antimicrobial properties of H2O2 have been studied in depth and are well known. Previous 
studies by some groups and experiments done by us have demonstrated that Nitric oxide 
potentiates hydrogen peroxide-induced killing of Escherichia coli [83, 84] (Figure 46). For 
prokaryotes subjected to oxidative injury, NO was found to enhance the bactericidal effect of 
H2O2, lending support to the concept that NO plays a critical role in host defense against 
invading pathogens. It has also been demonstrated in our studies that the presence of cyclic 
nitroxide antioxidants such as TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl) 
(Figure 46,47) protect the cells from the synergic killing effect [83]. 
Figure 45. Structure of Sodium Nitroprusside (SNP). 
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Figure 46. E.coli cell survival studies showing the synergistic activity of NO and H2O2 in solution. H2O2 alone 
shows some killing, however NO markedly potentiates H2O2-induced killing of E. coli. The antioxidant TEMPOL 
abrogates the synergic killing effect of NO and H2O2.  
Figure 47. Structure of the antioxidant 4-
hydroxy-2,2,6,6-tetramethylpiperidin-1-
oxyl (TEMPOL). 
TEMPOL  
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Based on our previous experiments the suggested mechanism for the NO and H2O2 
synergic killing effect is described below. 
A main route for H2O2 toxicity is through the formation of OH radicals (Hydroxyl 
radicals). This reaction is very slow but is catalyzed by iron, through the Haber-Weiss reaction. 
(See scheme below). In the cells, nitric oxide can release Iron ions from bacterial [4Fe-4S] 
protein clusters storage, thereby providing the catalyst for the Haber-Weiss reaction, forming OH 
radicals and resulting in a synergic killing effect. Moreover, nitroxides such as TEMPOL can 
effectively oxidize cellular redox-active metals and pre-empt the Fenton reaction explaining the 
abrogation of the synergic killing effect in the presence of TEMPOL [83]. 
 
 
 
 
 
 
 
 
 
Combination of H2O2 and NO is highly toxic to prokaryotes and has potential in 
antimicrobial therapy. However maintaining a constant H2O2 concentration for treatment 
becomes complicated because microorganisms have their own biological mechanisms for 
removal of H2O2 (using cellular catalases and peroxidases). To overcome this problem a 
sustained release of H2O2 and NO is required for treatment which will be able to continuously 
The Haber-Weiss Catalytic Cycle: 
Step I. Reduction of ferric ion to ferrous ion 
               Fe3+   + •O2
-    → Fe2+  + O2
 
Step II: The Fenton Reaction 
               Fe2+  +  H2O2
 
   → Fe3+  + OH- + •OH 
 
Net reaction: 
              •O2
- +  H2O2  
 
→ •OH + OH- +  O2 
82 
 
deliver the drugs to the bacterial cells. We have synthesized antibacterial, NO and H2O2 
generating nanogel delivery systems, by encapsulating the enzyme glucose oxidase (GOx) and 
the NO donor SNP inside the nanogels. These nanogels when exposed to dextrose and light will 
generate H2O2 and NO simultaneously in a controlled manner (Figure 48). We have also 
demonstrated that TEMPOL encapsulated nanogels protect bacterial cells from synergic killing 
by H2O2/NO combination.  Herein, we report a biocompatible mild synthetic approach to 
preparing NO and H2O2 generating nanogels which have the potential to act as treatment for 
combination therapy for multidrug resistant bacteria.  
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Figure 48. Illustration shows a combination of 
GOx and SNP nanogels, which when exposed 
to Glucose and Light generate NO and H2O2 
which are released into the surrounding 
solution.  
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Procedure  
Synthesis of NO generating nanogels.  
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 30 minutes (Bransonic). Potassium 
Phosphate Buffer pH 7 50mM (with desired SNP concentration) was added to the hydrolyzed 
TMOS solution (1:1 ratio). SNP was incorporated inside the sol-gel matrix during gelation. The 
sol-gels produced were dried at room temperature for 12 hours, slightly crushed using a spatula 
and lyophilized for 5 hours (LABCONCO Free Zone 2.5).  
 
Synthesis of H2O2 generating nanogels.  
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 30 minutes (Bransonic). Potassium 
Phosphate Buffer pH 7 50mM (with desired GOx concentration) was added to the hydrolyzed 
TMOS solution (1:1 ratio). GOx was incorporated inside the sol-gel matrix during gelation. The 
sol-gels produced were dried at room temperature for 12 hours, slightly crushed using a spatula 
and lyophilized for 5 hours. (LABCONCO Free Zone 2.5)  
 
Generation of H2O2 and NO from nanogels.  
The generation of H2O2 was measured using an iodide assay and UV/Visible spectroscopy 
(absorbance at 352 nm). The generation of NO was indirectly measured by nitrite determination 
using griess’s reagent. (Absorbance at 540nm) (thermo scientific nanodrop2000).  
 
 
 
 
85 
 
Dynamic Light Scattering and Zeta Potential Analysis  
DLS measurements were performed on a 90 plus particle size analyzer (Brookhaven Instruments 
Corporation) employing a 90° scattering angle and a 35 mW incident laser (658 nm). Small 
amounts of nanogels (1-2mg) were suspended in deionized water and sonicated for 15 minutes 
before taking measurements. The reported diameter is the average of 5 runs for each sample. 
Zeta Potential measurements were done by adding small amount (1-2mg) of nanogels in 1mM 
KCl solution and sonication for 15 minutes (Brookhaven Instruments Inc. Zeta Plus). 
Transmission Electron Microscope (TEM) Studies  
Dilute samples used for DLS measurements were mixed in a 1:1 ratio with 1% uranyl acetate, 
sonicated for 10 minutes. Then 5ul was put on a carbon film coated copper grid, 300 mesh 
(electron microscopy sciences, Hatfield, PA) and the excess solution was removed immediately 
using absorbent paper. The grids were dried overnight and viewed under the transmission 
electron microscope (JEOL, model JEM-1200 EX). Images were taken with a SIA–L3C CCD 
camera (Scientific Instruments and Applications, Inc.) using the software Maxim DL5 
(Diffraction Limited, Ottawa, Canada). 
E.coli experiments  
E. coli was grown aerobically at 37°C for 12-16 h with shaking (250 rpm) in Luria-Bertani 
medium (LB). The saturated cultures were diluted in fresh LB medium starting at (OD 600) 0.05 
(optical density) and incubated at 37 °C in Erlenmeyer flasks with vigorous shaking at 250 rpm 
as well until they reached a concentration of 2x10
5 
cells/ml. Each E.coli solution was incubated 
with different nanogels for a total time of 90 minutes. All samples were exposed to light and 
dextrose at time 0.  Catalase (10U/ml) was added to remove residual H2O2 and terminate the 
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oxidative stress. Four dilutions were made at each time interval and three 20 ul drops were plated 
from each dilution on solid agar plates. Plates were incubated overnight at 37
o
C and colonies 
counted. All results were compared to the control without any nanogels. 
Results 
DLS measurements showed that the effective diameter of the particles produced was between 
100-500 nm (Table 8). GOx and SNP nanogels are also colloidally stable as seen by the zeta 
potential of -35 and -31mV respectively (Table 9). 
 
 
 
              Table 8. Size of GOx and SNP nanogels as measured by Dynamic Light Scattering. 
 
Sample  Effective Diameter (nm)  
(from DLS) 
Size (nm) 
(from TEM) 
Control nanogels  428 60-100 
GOx encapsulated nanogels  294 20-100 
SNP nanogels  259 20-100 
 
 
 
              Table 9. Zeta Potential of GOx and SNP nanogels as measured by the Zeta Analyzer. 
 
Sample  Zeta Potential (mV) 
Control nanogels  -30 
GOx encapsulated nanogels  -35 
SNP nanogels  -31 
 
 
 
 
 
 
 
 
 
 
 
 
 
87 
 
Transmission electron micrographs show (Figure 49) that the nanogels are circular, well 
distributed particles in the size range of 20-100nm. 
 
 
 
 
                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49. TEM micrographs of a. SNP encapsulated 
nanogels, Scale Bar: 0.5µm; b. GOx encapsulated nanogels, 
Scale Bar: 0.5 µm. The average size of the nanogels for both 
samples range from 20-100nm. 
0.5 um 
a 
0.5 um 
b 
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Figure 50. a. Generation of H2O2 from GOx encapsulated nanogels upon exposure to glucose. The concentration 
of H2O2 at each time point was determined using an iodide assay (352nm); b. Generation of Nitrite from SNP 
encapsulated nanogels upon exposure to light. The concentration of Nitrite at each time point was determined 
using Griess reagent (540nm). 
GOx and SNP were successfully incorporated inside the nanogels.  As tested by UV visible 
spectroscopy it was seen that the GOx is not only successfully encapsulated within the sol-gel   
matrix, but is also functional as it is able to generate hydrogen peroxide upon addition of glucose 
to the nanogel solution. The generation of H2O2 was spectrophotometrically measured using an 
iodide assay (wavelength 352nm) (Figure 50a). When the nanogels are suspended in a solution 
of glucose, the glucose molecules are able to travel inside the porous matrix and react with the 
enzyme to generate H2O2, which is released out into the solution.  
 
Similarly, SNP encapsulated nanogels when exposed to light generate NO (NO is quickly 
converted to nitrite which can be measured by griess’s reagent at wavelength 540nm) (Figure 
50b).  
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Generation of H2O2 and NO from nanogels synthesized using Lyophilization protocol.  
H2O2 and NO generating nanogels were tested on cell survival of bacteria. During the 
experiments there was continuous monitoring of the concentrations of H2O2 and NO 
concentration using the iodide assay and Griess reagent respectively.  
 
The results demonstrated that GOx nanogels are able to show killing towards E.coli. Moreover 
the combination of GOx nanogels and SNP nanogels show much higher killing rate as compared 
to GOx alone. This effect is due to the H2O2/NO release combination (Figure 51). Using 
nanogels we were able to demonstrate the same effect as seen in solution indicating that nanogels 
are simultaneously able to deliver H2O2 and NO.  
 
 
When the GOx and SNP is encapsulated inside the same nanogels, the same combination of 
H2O2/NO toxicity is seen again (Figure 52). These results show the superior property of 
nanogels as a hybrid or multipurpose carrier.  
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Figure 51. a. Growth curves of E.Coli when incubated with different nanogels. GOx nanogels are able 
to show killing towards E.coli. Moreover the combination of GOx nanogels and SNP nanogels show 
much higher killing rate as compared to GOx alone. This effect is due to the H2O2/NO release 
combination; b. Concentration of nitrite as a function of time during the experiment (measured using 
Griess reagent); c. Concentration of H2O2 generated as a function of time during the experiment 
(measured using iodide assay).  
b 
c 
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Figure 52. Growth curves of E.Coli when incubated with hybrid nanogels containing all the chemicals in one 
nanogel matrix. When the GOx and SNP is encapsulated inside the same nanogels, the same combination 
H2O2/NO toxicity is seen again. 
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It was seen in solution experiments that TEMPOL is capable of protecting the bacterial cells 
from the H2O2/NO synergistic killing. When TEMPOL encapsulated nanogels are added to the 
combinations of GOx ngs and SNP ngs, the TEMPOL is able to diffuse put and protect the cells 
from killing (Figure 53). 
 
 
Generation of H2O2 and NO from nanogels synthesized using Polylysine protocol.  
Generation of H2O2 and NO was also achieved using nanogels produced using the Polycationic 
peptides. The nanogels were able to continuously generate H2O2 and NO and were able to show 
killing towards E.coli cells (Figure 54). 
 
 
Figure 53. E.coli cell survival study showing protection of E.coli cells from H2O2/NO toxicity by TEMPOL 
encapsulated nanogels. 
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Figure 54. a. Growth curves of E.Coli when incubated with H2O2 generating nanogels synthesized using the 
polylysine protocol, SNP was added externally; b. Concentration of nitrite as a function of time during the 
experiment (measured using Griess reagent); c. Concentration of H2O2 generated as a function of time during 
the experiment (measured using Iodide assay).  
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Nanogels synthesized using both protocols (Lyophilization and Polylysine protocol) displayed 
similar results. When E.Coli was incubated with GOx encapsulated nanogels, the growth curves 
showed substantial killing of the bacteria over time as compared to control bacteria, which was 
correlated to the H2O2 generated from the GOx nanogels (measured simultaneously). Moreover a 
combination of GOx encapsulated nanogels and SNP encapsulated nanogels displayed enhanced 
killing of the bacteria due to the potentiating effect of the NO released towards the killing effect 
of H2O2. 
 
Conclusions  
This study shows that enzymes and small molecules co-encapsulated inside the nanogel matrix 
are capable of carrying out multiple reactions and generate products in a sustained manner. We 
were able to reproduce results from H2O2/NO synergy solution studies inside nanogels. The 
H2O2 and NO generating nanogels that were studied here displayed good antibacterial activity 
against E.coli. This work integrates nanotechnology and bacteriology, leading to possible 
advances in the formulation of new types of bactericides. However, future studies on the biocidal 
influence of this nanomaterial on other Gram positive and Gram-negative bacteria are necessary 
in order to fully evaluate its possible use as a new bactericidal material. 
 
 
 
 
 
 
 
95 
 
CHAPTER 8 
OUTLOOK 
Important Features of Sol- Gel Based Nanoparticles  
One of the most useful properties of sol-gel based nanoparticles is easy and mild synthetic 
technique.  There is minimal effect of the silicate matrix on the properties of encapsulated 
therapeutic molecules and macromolecules and they remain effective and functional. Successful 
co-encapsulation of different biologically active agents can be achieved for multi targeted 
therapy. Our studies have shown sustained delivery of sol-gel co-encapsulation of therapeutic 
agents to bacterial cells. Moreover the nanogels in themselves exhibited a very low toxicity 
towards bacteria.  All these properties are highly desirable in a carrier matrix for therapeutic 
agents and show promise for further development.  
 
Future Development  
We have in this work developed recipes to easily synthesize nanogels and have characterized 
some aspects of these particles that will be useful for further development of them as therapeutic 
carriers. There are still interesting questions which are worthwhile to explore, and further 
developments are necessary. It would also be interesting to conduct studies to find different silica 
precipitating agents to improve biomimetic methods for production of non-toxic and inert 
nanoparticles. Further investigations into effect of these nanogels on different kinds of 
microorganisms would be useful for advancement of such nanoparticles for antimicrobial 
therapy. Although there have been some studies on intake of silicate nanoparticles by 
mammalian cells, interactions between nanogels and cells are not fully understood and need 
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further probing. Studies in mammalian cell cultures are needed. Assessment of bio-distribution 
and blood circulation levels and interaction with serum proteins need to be studied in detail and 
testing in animal models is required for further development of nanogels for therapeutic 
purposes. 
 
Potential Applications  
Nanogels offer potential for various kinds of interesting applications which we came across as 
we developed methods to synthesize and characterize them. An important application is 
Multidrug resistance antibiotic therapy for infections such as Methicillin-resistant 
Staphylococcus aureus (MRSA). Combination therapy using various antibiotic agents would be 
compatible with the nanogel carrier as shown in our studies. Since the nanogel matrix can hold 
proteins intact and unharmed, it has potential to be used in diagnostics and biosensor fields. 
Further developments into surface modification of the nanogels would also enable them to be 
used as inert, nontoxic agents for potential antitumor therapy.   
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ABBREVIATIONS  
APTES  3- Amino propyl triethoxy silane  
DLS  Dynamic Light Scattering  
DTT Sodium Dithionite  
FTIR Fourier Transform Infrared spectroscopy 
GOx Glucose Oxidase  
Hb  Hemoglobin  
Mb Myoglobin  
ngs Nanogels 
NO Nitric Oxide  
nps Nanoparticles  
PEG  Polyethylene glycol  
PLL Poly-L-Lysine  
SNP Sodium Nitroprusside  
Soln.  solution 
TEM Transmission Electron Microscopy  
TEMPOL  4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl 
Tf Transferrin 
THPMP  3-(trihydroxysilyl) propyl methyl phosphonate  
TMOS Tetra methyl orthosilicate 
TQ Thymoquinone 
UV/Vis  UV visible spectroscopy 
 
 
 
 
 
 
 
 
98 
 
BIBLIOGRAPHY  
1. Torchilin VP. 2007. Targeted Pharmaceutical Nanocarriers for Cancer Therapy and Imaging.   
    AAPS 9:E128-E147. 
 
2. Mozaferi MR. 2006. Bioactive Entrapment and Targeting using Nanocarrier Technologies: An      
    Introduction. 1-16 p. 
 
3. Kabanov AV, Vinogradov SV. 2009. Nanogels as Pharmaceutical Carriers:Finite Networks of  
    Infinite Capabilities. Angew. Chem. Int. Ed. 48:5418-5429. 
 
4. Wright, J. D., and N. A. J. M. Sommerdijk. 2001. Sol Gel Materials Chemistry and    
    Applications. CRC Press. 
 
5. Avnir D, Coradin T, Lev O, Livage J. 2005. Recent bio-applications of sol-gel materials.                                                            
    J.Mater. Chem. 16:1013-1030. 
 
6. Kroger N, Deutzmann R, Sumper M. 1999. Polycationic Peptides from Diatom Biosilica That                                            
    Direct Silica Nanosphere Formation. Science 286:1129-1132. 
 
7. Luckarift, H.R., J.C. Spain, R.R. Naik, and M.O. Stone. 2004. Enzyme immobilization in a   
    biomimetic silica support. Nat Biotech. 22: 211–213. 
 
8. Naik RR, Tomczak MM, Luckarift HR, Spain JC, Stone MO. 2004. Entrapment of enzymes                                     
    and nanoparticles using biomimetically synthesized silica. Chem. Commun.:1684-1685.          
 
9. Tomczak MM, Glawe DD, Drummy LF, Lawrence CG, Stone MO, Perry CC, Pochan DJ,                     
    Deming TJ, Naik RR. 2005. Polypeptide- Templated Synthesis of Hexagonal Silica Platelets.     
    J.AM.CHEM.SOC. 127:12577-12582. 
 
10. Hench LL, West JK. 1990. The sol-gel process. Chemical Reviews Chem. Rev. 90(1):33-72. 
 
11. Takayama K, Nakase I, Michiue H, Takeuchi T, Tomizawa K, Matsui H, Futaki S. 2009.        
      Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration          
      accelerating sequences (Pas). Journal of Controlled Release 138(2):128-133. 
 
12.  Nakase, I., Y. Konishi, M. Ueda, H. Saji, and S. Futaki. 2012. Accumulation of arginine-rich 
cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo. J. 
Control. Release. 159: 181–188. 
 
13.  Ma, D.X., N.Q. Shi, and X.R. Qi. 2011. Distinct transduction modes of arginine-rich cell-
penetrating peptides for cargo delivery into tumor cells. Int. J. Pharm. 419: 200–208. 
 
14. Åmand, H.L., H.A. Rydberg, L.H. Fornander, P. Lincoln, B. Nordén, et al. 2012. Cell surface 
binding and uptake of arginine and lysine-rich penetratin peptides in absence and presence of 
proteoglycans. Biochim. Biophys. Acta - Biomembr. 1818: 2669–2678. 
99 
 
 
15. Tolnai G, Csempesz F, Kabai-Faix M, Kalman E, Keresztes Z, Kovacs AL, Ramsden JJ,                    
      Horvolgyi ZS. Preparation and charac- terization of surface-modified silica-nanoparticles.                                     
      Langmuir 2001;17:2683–2687. 
 
16. Bijsterbosch HD, Cohen Stuart MA, Fleer GJ. Effect of block and graft copolymers on the   
      stability of colloidal silica. J Colloid Interf Sci 1999;210:37–42. 
 
17. Vincent B. The preparation of colloidal particles having (post- grafted) terminally-attached   
      polymer chains. Chem Eng Sci 1993;48:429–436. 
 
18. Napper DH. Steric stabilization. J Colloid Interf Sci 1977;58: 390–407. 
 
19. Kim KS, Cho SH, Shin JS. Preparation and characterization of monodisperse polyacrylamide  
      microgels. Polym J 1995;27:508– 514. 
 
20. Gref R, Luck M, Quellec P, Marchand M, Dellacherie Harnisch S, Blunk T, Muller RH.  
     ‘Stealth‘ corona-core nanoparticles surface modified by polyethylene glycol (PEG):    
Influences of the corona (PEG chain length and surface density) and of the core composition 
on phagocytic uptake and plasma protein adsorption. Colloids Surf B 2000;18:301–313. 
 
21. Harris M. Poly(ethylene glycol) chemistry: Biotechnical and biomedical applications. New  
      York: Plenum Press; 1992. 
 
22. Bagwe, R.P., L.R. Hilliard, and W. Tan. 2006. Surface Modification of Silica Nanoparticles     
      to  Reduce Aggregation and Nonspecific Binding. Langmuir. 22: 4357–4362. 
 
23. Weed, Robert I.; Reed, Claude F. and Berg, George (1963). Is hemoglobin an essential     
structural component of human erythrocyte membranes?. J Clin Invest. 42(4): 581–8. 
 
24. Simoni, R.D., R.L. Hill, and M. Vaughan. 2002. The Structure and Function of Hemoglobin: 
Gilbert Smithson Adair and the Adair Equations. J. Biol. Chem. 277: e20. 
 
25. Perutz MF, Rossmann MG, Cullis MG, Muirhead H, Will G, North ACT. 1960. Structure of 
haemoglobin. A three-dimensional Fourier synthesis at 5.5Å resolution, obtained by X-ray 
analysis.Nature. (185):416–422 
 
26. Perutz MF, Lehmann H. Molecular pathology of human haemoglobin. 1968. Nature. 
219(157):902–909 
 
27. S. Bando, T. Takano, T. Yubisui, K. Shirabe, M. Takeshita and A. Nakagawa.2004. Structure 
of human erythrocyte NADH-cytochrome b5 reductase. Acta Cryst. D60, 1929-1934.     
 
28. Gibson, Q.H., B.E.P. Swoboda, and V. Massey. 1964. Kinetics and Mechanism of Action of 
Glucose Oxidase. J. Biol.Chem. 239: 3927–3934. 
 
100 
 
29. Swoboda BEP, Massey V. 1965. Purification and Properties of the Glucose Oxidase  
      from Aspergillus niger. Journal of Biological Chemistry 240:2209-2215. 
 
30. Liu S, Tian J, Wang L, Luo Y, Lu W, Sun X. 2011. Self-assembled graphene platelet–
glucose oxidase nanostructures for glucose biosensing. Biosensors and Bioelectronics 
26(11):4491-4496. 
 
31. Periasamy, A.P., Y.-J. Chang, and S.-M. Chen. 2011. Amperometric glucose sensor based on 
glucose oxidase immobilized on gelatin-multiwalled carbon nanotube modified glassy carbon 
electrode. Bioelectrochemistry. 80: 114–20. 
 
32. Yang, F., J.B. Lum, J.R. McGill, C.M. Moore, S.L. Naylor, et al. 1984. Human transferrin: 
cDNA characterization and chromosomal localization. Proc. Natl. Acad. Sci. . 81 : 2752–
2756. 
 
33. Aisen, P., A. Leibman, and J. Zweier. 1978. Stoichiometric and site characteristics of the 
binding of iron to human transferrin. J. Biol.Chem.. 253 : 1930–1937. 
 
34. Tortorella, S., and T. Karagiannis. 2014. Transferrin Receptor-Mediated Endocytosis: A 
Useful Target for Cancer Therapy. J. Membr. Biol. 247: 291–307. 
 
35. Chiu, R.Y.T., T. Tsuji, S.J. Wang, J. Wang, C.T. Liu, et al. 2014. Improving the systemic 
drug delivery efficacy of nanoparticles using a transferrin variant for targeting. J. Control. 
Release. 180: 33–41. 
 
36. Storch S, Kübler B, Höning S, Ackmann M, Zapf J, Blum W, Braulke T. 2001. Transferrin 
binds insulin-like growth factors and affects binding properties of insulin-like growth factor 
binding protein-3. FEBS Letters 509(3):395-8. 
 
37. Ritchie, R.F., G.E. Palomaki, L.M. Neveux, O. Navolotskaia, T.B. Ledue, et al. 1999. 
Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and 
transthyretin: A practical, simple and clinically relevant approach in a large cohort. J. Clin. 
Lab. Anal. 13: 273–279. 
 
38. Tortorella S FAU - Karagiannis TC, TC K. 2014. The Significance of Transferrin Receptors 
in Oncology: the Development of Functional Nano-Based Drug Delivery Systems. Current 
Drug Delivery:1875-5704. 
 
39. Tortorella, S., and T. Karagiannis. 2014. Transferrin Receptor-Mediated Endocytosis: A 
Useful Target for Cancer Therapy. J. Membr. Biol. 247: 291–307. 
 
40. Szwed, M., A. Matusiak, A. Laroche-Clary, J. Robert, I. Marszalek, et al. 2014. Transferrin 
as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin 
transferrin conjugate in the human leukemia cells. Toxicol. Vitr. 28: 187–197. 
 
101 
 
41. Edson, R.S., and C.L. Terrell. 1987. The Aminoglycosides: Streptomycin, Kanamycin, 
Gentamicin, Tobramycin, Amikacin, Netilmicin, and Sisomicin. Mayo Clin. Proc. 62: 916–
920. 
 
42. Misumi, M., and N. Tanaka. 1980. Mechanism of inhibition of translocation by kanamycin 
and viomycin: A comparative study with fusidic acid. Biochem. Biophys. Res. Commun. 92: 
647–654. 
 
43. Jesús Cabañas, M., D. Vázquez, and J. Modolell. 1978. Inhibition of ribosomal translocation 
by aminoglycoside antibiotics. Biochem. Biophys. Res. Commun. 83: 991–997. 
 
44. Newman DJ.2008. Natural products as leads to potential drugs: an old process or the new 
hope for drug discovery? Journal of medicinal chemistry.51:2589–99. 
 
45. Al-Ali A, Alkhawajah AA, Randhawa MA, Shaikh NA. 2008 Oral and intraperitoneal LD50 
of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll 
Abbottabad.20:25–7.  
 
46. Morikawa T, Xu F, Kashima Y, Matsuda H, Ninomiya K, Yoshikawa M. 2004. Novel 
dolabellane-type diterpene alkaloids with lipid metabolism promoting activities from the 
seeds of Nigella sativa. Organic letters. 6:869–72.  
 
47. Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N, Crooks PA. 2004. Molecular 
pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic 
keratinocytes. Anti-cancer drugs.15:389–99.  
 
48. Gali-Muhtasib H, Ocker M, Kuester D, Krueger S, El-Hajj Z, Diestel A, et al. 2008. 
Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine 
colon cancer models. Journal of cellular and molecular medicine.12:330–42. 
 
49. Roepke M, Diestel A, Bajbouj K, Walluscheck D, Schonfeld P, Roessner A, et al. 2007. Lack 
of p53 augments thymoquinone-induced apoptosis and caspase activation in human 
osteosarcoma cells. Cancer biology & therapy.6:160–9.  
 
50. Shoieb AM, Elgayyar M, Dudrick PS, Bell JL, Tithof PK. 2003 In vitro inhibition of growth 
and induction of apoptosis in cancer cell lines by thymoquinone. International journal of 
oncology. 22:107–13. 
 
51. El-Mahdy MA, Zhu Q, Wang QE, Wani G, Wani AA. 2005. Thymoquinone induces 
apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic 
leukemia HL-60 cells. International journal of cancer.117:409–17.  
 
52. Tan M, Norwood A, May M, Tucci M, Benghuzzi H. 2006. Effects of (−)epigallocatechin 
gallate and thymoquinone on proliferation of a PANC-1 cell line in culture. Biomedical 
sciences instrumentation. 42:363–71.  
 
102 
 
53. Worthen DR, Ghosheh OA, Crooks PA. 1998 The in vitro anti-tumor activity of some crude 
and purified components of blackseed, Nigella sativa L. Anticancer research.18:1527. 
 
54. Ravindran J, Nair HB, Sung B, Prasad S, R. R, Tekmal, Aggarwal BB. 2010. Thymoquinone 
Poly(lactide-co-glycolide) Nanoparticles Exhibit Enhanced Anti-proliferative, Anti-
inflammatory, and Chemosensitization Potential. Biochemical Pharmacology 79(11):1640–
1647. 
 
55. Buynak, J.D. 2006. Understanding the longevity of the β-lactam antibiotics and of 
antibiotic/β-lactamase inhibitor combinations. Biochem. Pharmacol. 71: 930–940. 
 
56. Monaghan, R.L., and J.F. Barrett. 2006. Antibacterial drug discovery—Then, now and the 
genomics future. Biochem. Pharmacol. 71: 901–909. 
 
57. Bedenic, B., J. Vranes, S. Suto, and Z. Zagar. 2005. Bactericidal activity of oral β-lactam 
antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and 
extended-spectrum β-lactamases. Int. J. Antimicrob. Agents. 25: 479–487. 
 
58. Sohrabi, A., P.M. Shaibani, H. Etayash, K. Kaur, and T. Thundat. 2013. Sustained drug 
release and antibacterial activity of ampicillin incorporated poly(methyl methacrylate)–
nylon6 core/shell nanofibers. Polymer (Guildf). 54: 2699–2705. 
 
59. Lode, H.M. 2008. Rational antibiotic therapy and the position of ampicillin/sulbactam. Int. J. 
Antimicrob. Agents. 32: 10–28. 
 
60. Ciucci, A., G. Feriotto, C. Mischiati, R. Gambari, F. Animati, et al. 1994. Distamycin 
analogues with improved sequence-specific DNA binding activities. Biochem. Pharmacol. 
48: 1583–1591. 
 
61. Hiraku, Y., S. Oikawa, and S. Kawanishi. 2002. Distamycin A, a minor groove binder, 
changes enediyne-induced DNA cleavage sites and enhances apoptosis. Nucleic Acids Res. 
Suppl.: 95–6. 
 
62.  Krey, a K., and F.E. Hahn. 1970. Studies on the complex of distamycin a with calf thymus 
DNA. FEBS Lett. 10: 175–178. 
 
63. Zunino, F., and A. Di Marco. 1972. Studies on the interaction of distamycin A and its 
derivatives with DNA. Biochem. Pharmacol. 21: 867–873. 
 
64. Riou, J.-F., L. Grondard, A. Naudin, and C. Bailly. 1995. Effects of two distamycin-
ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to 
cytotoxicity. Biochem. Pharmacol. 50: 424–428. 
 
65. Tabrez Khan, S., M. Ahamed, A. Al-Khedhairy, and J. Musarrat. 2013. Biocidal effect of 
copper and zinc oxide nanoparticles on human oral microbiome and biofilm formation. 
Mater. Lett. 97: 67–70. 
103 
 
 
66. Sondi, I., and B. Salopek-Sondi. 2004. Silver nanoparticles as antimicrobial agent: a case 
study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 275: 177–
82. 
 
67. McShan, D., P.C. Ray, and H. Yu. 2014. Molecular toxicity mechanism of nanosilver. J. 
Food Drug Anal. 22: 116–127. 
 
68. Taju, G., S. Abdul Majeed, K.S.N. Nambi, and A.S. Sahul Hameed. 2014. In vitro assay for 
the toxicity of silver nanoparticles using heart and gill cell lines of Catla catla and gill cell 
line of Labeo rohita. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 161: 41–52. 
 
69. García-Alonso, J., N. Rodriguez-Sanchez, S.K. Misra, E. Valsami-Jones, M.-N. Croteau, et 
al. 2014. Toxicity and accumulation of silver nanoparticles during development of the marine 
polychaete Platynereis dumerilii. Sci. Total Environ. 476–477: 688–695. 
 
70. Hadrup, N., and H.R. Lam. 2014. Oral toxicity of silver ions, silver nanoparticles and 
colloidal silver – A review. Regul. Toxicol. Pharmacol. 68: 1–7. 
 
71. Qin, Y., and C. Zhu. 2010. Antimicrobial Properties of Silver-Containing Chitosan Fibers. 
In: Anand SC, JF Kennedy, M Miraftab, SBT-M and HT Rajendran, editors. Woodhead 
Publishing Series in Textiles. Woodhead Publishing. pp. 7–13. 
 
72. Melo, M.A.S., L. Cheng, K. Zhang, M.D. Weir, L.K.A. Rodrigues, et al. 2013. Novel dental 
adhesives containing nanoparticles of silver and amorphous calcium phosphate. Dent. Mater. 
29: 199–210. 
 
73. Mu, S., Z. Wu, S. Qi, D. Wu, and W. Yang. 2010. Preparation of electrically conductive 
polyimide/silver composite fibers via in-situ surface treatment. Mater. Lett. 64: 1668–1671. 
 
74. Wink, D.A., and J.B. Mitchell. 1998. Chemical biology of nitric oxide: insights into 
regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 
25: 434–456. 
 
75. Marcinkiewicz, J. 1997. Nitric oxide and antimicrobial activity of reactive oxygen 
intermediates. Immunopharmacology. 37: 35–41. 
 
76. Wink, D.A., I. Hanbauer, M.B. Grisham, F. Laval, R.W. Nims, et al. 1996. Chemical biology 
of nitric oxide: Regulation and protective and toxic mechanisms. In: Regulation ERS and 
PBCBT-CT in C, editor. Academic Press. pp. 159–187. 
 
77. Wink, D.A., Y. Vodovotz, M.B. Grisham, W. DeGraff, J.C. Cook, et al. 1999. [43] 
Antioxidant effects of nitric oxide. In: Enzymology LPBT-M in, editor. Nitric Oxide Part C: 
Biological and Antioxidant Activities. Academic Press. pp. 413–424. 
 
104 
 
78. Schairer, D.O., J.S. Chouake, J.D. Nosanchuk, and A.J. Friedman. 2012. The potential of 
nitric oxide releasing therapies as antimicrobial agents. Virulence. 3: 271–9. 
 
79. Zhou, Z., and M.E. Meyerhoff. 2005. Polymethacrylate-based nitric oxide donors with 
pendant N-diazeniumdiolated alkyldiamine moieties: synthesis, characterization, and 
preparation of nitric oxide releasing polymeric coatings. Biomacromolecules. 6: 780–9. 
 
80. Pavlos, C.M., H. Xu, and J.P. Toscano. Photosensitive Precursors to Nitric Oxide. Curr. Top. 
Med. Chem. 5: 637–647. 
 
81. Wink, D.A., J.A. Cook, R. Pacelli, W. DeGraff, J. Gamson, et al. 1996. The Effect of 
Various Nitric Oxide-Donor Agents on Hydrogen Peroxide-Mediated Toxicity: A Direct 
Correlation between Nitric Oxide Formation and Protection. Arch. Biochem. Biophys. 331: 
241–248. 
 
82. Tinker, J.H., and J.D. Michenfelder. 1976. Sodium Nitroprusside: Pharmacology, Toxicology 
and Therapeutics. Anesthesiology. 45. 
 
83. Yadav, R., Y. Samuni, A. Abramson, R. Zeltser, N. Casap, et al. 2014. Pro-oxidative    
      synergic bactericidal effect of NO: kinetics and inhibition by nitroxides. Free Radic. Biol.    
      Med. 67: 248–254. 
 
84.  Pacelli, R., D.A. Wink, J.A. Cook, M.C. Krishna, W. DeGraff, et al. 1995. Nitric oxide   
       potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med.182 :        
       1469–1479. 
 
 
 
 
 
 
 
 
